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ABSTRACT 
 
This thesis investigated the effects of acute eccentric exercise on the immune response to 
vaccination in young humans.  Study one investigated whether the efficacy of the eccentric 
exercise intervention was affected by manipulating the timings of exercise prior to influenza 
vaccination.  Three exercise groups were vaccinated immediately, 6 hr or 48 hr after exercise and 
antibody responses at 28 days post-vaccination were compared to those from a resting control 
group.  All participants exhibited robust antibody responses to the vaccine and no effect of 
exercise was observed; therefore, it was not possible to determine the effects of exercise timing 
on vaccine responses.  Study two investigated whether the antibody response to influenza 
vaccination was influenced by the intensity of eccentric exercise.  Three groups exercised at an 
intensity eliciting 60%, 85% or 110% of one repetition maximum, and the antibody responses at 
28 days post-vaccination were compared to those from a resting control group.  In the exercise 
groups, both men and women showed enhanced antibody responses against the B/Florida strain, 
and men had enhanced responses against A/Uruguay, in comparison to resting controls.  In both 
cases, the control group exhibited poorer responses against these strains, but no effect of exercise 
intensity was observed.  Study three investigated whether the site of vaccine administration 
affected the efficacy of the immune response to hepatitis B vaccination following eccentric 
exercise.  The antibody seroconversion rate to the vaccine was low (approx. 5 %), and thus, 
further analysis between exercise and control participants was not feasible.  In sum, supporting 
previous research, it appears that acute eccentric exercise can enhance the immune response to 
poorly immunogenic strains of influenza, but research is needed to establish if exercise can 
enhance other poorly immunogenic vaccines, or vaccine responses in the immuno-compromised. 
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CHAPTER ONE 
 
ECCENTRIC EXERCISE AS A BEHAVIOURAL ADJUVANT TO 
VACCINATION 
 
INTRODUCTION 
 
The introduction of vaccines against diseases has been one of the most successful public health 
interventions ever and, at present, is the most effective and cost-efficient method of disease 
prevention in humans (Nicholson et al. 2003).  Despite the remarkable success of vaccination, 
there are variations in the efficacy of some vaccines, and many are only capable of inducing 
poorly immunogenic responses.  For example, the effectiveness of influenza vaccination at 
preventing disease can be as high as 71 %, but there is research to suggest that the efficacy may 
be as low as 53 % in healthy adults (Villari et al. 2004), whereas other vaccines such as hepatitis 
B induce even poorer immune responses, and further ‘booster’ vaccinations are thus required 
(Hilleman, 2000).  Given the often poor immunogenicity of some common vaccines, there is a 
large body of research now devoted to developing adjuvants to improve immune responses 
(Aguilar and Rodriguez, 2007).   
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The immune responses to vaccination and the role of adjuvants 
 
The immune response to vaccination is characterised by a synergistic activation of both the innate 
and adaptive immune systems to execute an effective response to the antigens contained within 
the vaccine.  Upon first exposure to antigen following intra-muscular injection, antigen 
presenting cells (APCs) of the innate immune system, typically the tissue-specific dendritic cells, 
recognise antigen, before migrating to the lymph nodes to present the processed antigen to CD4+ 
T cells via MHC class II signalling to T cell receptor (CD3).  Following a reduction of the 
CD45RA receptor, and upon receipt of a secondary signal via the co-stimulatory molecule CD28 
with CD80 or CD86 on the APC, these antigen specific CD4+ T cells then differentiate.  
Differentiation is driven by the rapid release of potent T cell growth-factor, the cytokine IL-2, 
that in combination with interferon-γ (IFN- γ), leads to the development of Th1 CD4+ T cells.  
In addition, IL-4 is released which leads to the creation of Th2 CD4+ T Cells.   Th1 CD4+ T cells 
drive cell-mediated responses, whereas Th2 CD4+ T cells provide signalling to naïve B cells that 
drive humoral responses to the vaccine.  The cell-mediated response is characterised by high 
proliferation of CD8+ T cells that are capable of releasing cytotoxic agents (e.g., perforin, 
granzyme A, granzyme B) that kill infected host cells.  The humoral response is mostly 
comprised of antigen specific B cells which release antibodies.  The process described above is a 
thymus-dependent response, in which the help of T cells is required to initiate an antibody 
responses from B cells.  A thymus-dependent response occurs when a protein antigen is 
encountered, and this is the most common type of antibody response.  In contrast, thymus 
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independent responses occur with exposure to polysaccharide vaccines; in this process, B cells 
are able to generate a response without T cell help. 
 
The first class of antibody released during a primary infection are IgM antibodies; these bind 
antigen with high avidity, due to their pentameric formation and have the ability to activate 
complement.  IgG antibodies are also released during a primary response, and do not typically 
peak until approximately 4 weeks post-vaccination.  When the initial threat of infection has 
passed, the primary response to antigen is scaled back, and memory B and T cells remain in the 
event of re-infection with similar antigenic challenge. The secondary immune response is a much 
more rapid response that functions on the pre-existence of specific memory B and T cells.  Upon 
re-infection with the same antigen, APCs present to antigen-specific memory cells, and they 
rapidly undergo clonal expansion and produce specific IgG much more quickly than during the 
primary response.   
 
Adjuvants, (from Adjuvare: Latin, meaning to help) have been described as the immunologist’s 
‘dirty little secret’ (Janeway, Jr., 1989) and are agents that can stimulate the immune system.  
They can be broadly separated into two subcategories:  exogenous and endogenous adjuvants.  
Exogenous adjuvants can be chemicals (e.g., alum, oils and detergent) or microbial components 
or toxins (e.g., lipopolysaccharide and Pertussis toxin) and typically function by promoting 
recognition by the innate immune system, which subsequently enhances the speed and magnitude 
of the adaptive immune response (Aguilar and Rodriguez, 2007).  Despite the advances made 
using exogenous adjuvants, the efficacy of many vaccines remains low and the pursuit of new 
strategies to promote immune responses is desired.  As a result, research has recently begun to 
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focus on the role of endogenous adjuvants to vaccination (Rock et al. 2005).  Endogenous 
adjuvants are agents produced by various cells of the body that, like exogenous adjuvants, 
promote the activity of APCs which in turn increases the speed and magnitude of immune 
responses (Rock et al. 2005).  ‘Danger signals’ (e.g., IL-6) are released from sites around the 
body in response to acute physical (Edwards et al. 2006b) or immunological stress and assist in 
the activation of both innate and adaptive arms of the immune system (Matzinger, 2002).  
 
The role of behaviourally-induced endogenous adjuvants to vaccination 
 
The acute-stress immuno-enhancement hypothesis (Edwards et al. 2007b) has been developed 
based on a number of studies suggesting that acute stress, experienced at close temporal 
proximity to vaccine administration, may induce endogenous adjuvants and thus augment the 
subsequent immune response.  For a number of years, researchers have suggested that, from an 
evolutionary standpoint, acute stress is an integral component of the fight or flight response 
(Dhabhar and McEwen, 1999).  This response initiates a series of immunological changes, 
presumably in anticipation of exposure to antigenic challenge, with the primary aim of 
maximising immune responses against the antigen.  The literature surrounding this area is mainly 
comprised of research conducted in animals, with an increasing number of studies also conducted 
in humans.  In order to assess the effectiveness of the immune responses to vaccination, 
researchers in this area have typically investigated either humoral immunity status (e.g., specific 
antibodies from memory B lymphocytes) or cellular responses (e.g., delayed type 
hypersensitivity reactions or interferon γ response to in vitro stimulation).  In animals, a variety 
of behavioural stressors have been used, including restraint stress, inescapable footshock, and 
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exercise.  Restraint stress involves placing the animal in a ventilated plastic tube.  The animals 
are not physically squeezed or harmed; instead, it is conceived as a psychological stressor due to 
the feeling of confinement (Glavin et al. 1994).  Inescapable footshock involves animals 
receiving random electric shocks delivered through a wired floor, cage or box.  During exercise, 
the animals are typically exposed to exercise on a treadmill until a certain time elapses, or until 
volitional exhaustion.  Human studies have typically used exercise with either dynamic whole-
body exercise (e.g., cycling) or isolated muscle actions of isolated muscle groups (e.g., eccentric 
movements).  Human studies using psychological stress have utilised a naturalistic stressor, such 
as an examination, or more contrived laboratory stress-tasks, such as public speaking or mental 
arithmetic.  Regardless of the mode chosen, the hypothesis is that the stressor temporarily primes 
the immune system, to a similar extent, and augments the response to any proximal pathogen 
exposure.   
 
ACUTE STRESS-INDUCED ENHANCEMENT OF VACCINATION RESPONSES:  
EVIDENCE FROM ANIMALS 
 
Acute stress-induced enhancement of vaccination response in animals:  humoral immunity 
 
Studies conducted in animals investigating the effects of acute stress on the humoral response to 
vaccination support the stress-induced immuno-enhancement hypothesis.  For example, Millan 
and colleagues investigated whether short or long duration restraint stress affected the antibody 
response to sheep red blood cell (SRBC) inoculation in rats.  In this study, all rats were 
inoculated immediately prior to the stressor.  Results indicated that rats exposed to short periods 
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of restraint stress (2 hours over 2 consecutive days) had higher primary antibody titres at 7 days 
post-immunisation compared with control rats.  Further, no differences were observed between 
rats exposed to long stress (6 hours over 4 consecutive days) and control rats.  This finding 
highlights the important distinction between acute and chronic stress, whereby acute stress 
appears to enhance whereas chronic stress appears to suppress immune responses (Millan et al. 
1996).   
 
In a similar study investigating acute stress and antibody responses to SRBC inoculation, it was 
found that 2 hours of restraint stress immediately prior to vaccination enhanced the primary IgG 
response 10 days post-inoculation (Silberman et al. 2003).  The animals were then given another 
SRBC inoculation on day 11 and the secondary IgG antibody responses were measured on day 
18.  Animals exposed to acute stress at the time of primary inoculation also showed enhanced 
secondary responses compared with control animals.   Another group of animals exposed to 
chronic stress at the time of primary inoculation showed poorer primary and secondary IgG 
responses to the vaccine.  These results again indicate that exposure to an acute stressor may 
augment antibody responses, whereas prolonged periods of stress do not. 
 
In a study conducted by Wood and colleagues, it was found that rats exposed to electrical 
footshock on the day of, and the day after, keyhole limpet hemocyanin (KLH) inoculation had 
enhanced IgG antibody responses at 17 days post-vaccination, compared with control rats.  Rats 
exposed to electrical footshock one day, or three days, post-vaccination did not show augmented 
responses compared with control (Wood et al. 1993).  These results seem to highlight the 
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importance of vaccinating at close temporal proximity to the acute stress exposure, as otherwise, 
it seems that the adjuvant effect is either reduced or lost. 
 
Persoons and colleagues investigated the effects of stress exposure on the antibody responses to 
trinitrophenol-KLH (TNP-KLH) inoculation.  In this study, 20 minutes of electrical footshock 
immediately prior to intracheal TNP-KLH vaccination augmented the IgA, IgE and IgG antibody 
responses of these stressed animals, compared with non-stressed controls (Persoons et al. 1995).  
Persoons and colleagues hypothesised that acute stress augmented these responses by stimulating 
the release of cytokines from activated macrophages in the alveoli.  Although speculative, this 
idea supports the general contention that acute stress has the potential to augment processes 
involved in the early stages of immune responses, such as antigen identification and presentation.  
 
Karp and colleagues found that mice exposed to restraint stress immediately after (KLH) 
vaccination showed enhanced IgM antibody responses at three time points post-inoculation (8, 14 
and 21 days).  The authors of this study were interested in whether restraint stress could enhance 
the humoral response in immuno-deficient mice, modelling the poorer immune systems seen in 
elderly adults.  The results indicated that mice administered an immunosuppressive drug, 
cyclophosphamide, prior to vaccination appeared to show the largest increase in antibody 
responses when exposed to restraint stress (Karp et al. 2000).  These findings appear to illustrate 
that acute stress exposure may be more beneficial at augmenting immune responses in 
circumstances where poorer responses would otherwise be expected.  In addition, it seems that 
more robust responses, as seen in the control mice, are less enhanced by stress.  
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To our knowledge, only one study has investigated the effects of acute exercise on the humoral 
immune response to vaccination in animals.  In this study, Kapasi and colleagues randomly 
allocated young and old mice previously inoculated with human serum albumin (HSA) to one of 
three groups.  Two groups were exposed to a single bout of exhaustive intense exercise and 
immediately re-administered an HSA inoculation. The first group did not exercise further, but the 
second group continued with a more chronic regimen of daily bouts of intense exercise to 
exhaustion for 9 days. The third group acted as a control group and did not undergo intense 
exercise, but received the booster injection of HSA at the same time as the other groups.  Results 
indicated no effects of acute or chronic exercise on the antibody response to HSA in young mice.  
However, older mice exposed to the acute exercise condition had elevated antibody responses in 
comparison to other older mice in either the control group or the chronic exercise group. Further, 
control young mice had higher antibody responses than control elderly mice, but elderly mice 
exposed to the acute exercise task had antibody responses similar to those seen in the young mice 
(Kapasi et al. 2000).  These findings lend further support to the notion that acute stress may have 
the potential to help return otherwise weak immune responses to more “normal” levels (Karp et 
al. 2000).  
 
In summary, the animal literature offers strong evidence to suggest that acute stress administered 
at close temporal proximity to vaccination can enhance both the primary and secondary antibody 
responses.  Further, the data suggest that poorer immune responses may be particularly enhanced 
by acute stress, and that this augmentation appears to result from early interactions in the immune 
response to antigenic challenge.  Despite the majority of literature supporting this line of 
research, it should be conceded that not all acute stress studies have found enhancements to 
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vaccine responses.  In a study by Laudenslager and colleagues, IgG antibody responses to KLH 
were examined in rats following either one or three daily exposures to tail shock.  Results 
indicated that all animals exposed to shock showed reduced levels of IgG antibodies to KLH 
regardless of the experimental conditions of shock exposure (Laudenslager et al. 1988).  These 
findings were supported in a second study by this group, showing that antigen-specific total IgG, 
IgG1 and IgG2 antibodies were decreased in rats exposed to acute footshock.  The authors 
suggest that antibody responses that are T-cell dependent are more susceptible to stress-induced 
immuno-suppression (Gazda et al. 2003).  Together, these findings remain inconsistent with other 
findings in the field, and given that the type of stressor, duration of stressor and animals 
experimented on, are similar to those used in other studies showing an immune enhancement by 
acute stress, the reasons underpinning these inconsistencies remain unknown.  Despite these 
contrasting results in the literature, the majority of studies investigating the effects of acute 
physical and psychological stress on the humoral response in animals support the acute-stress 
immuno-enhancement hypothesis.   
 
Acute stress-induced enhancement of vaccination response in animals:  cellular immunity 
 
Cellular immunity in animals is the most researched area in the acute stress and vaccination 
literature.  A large number of studies have been conducted and the majority show that acute stress 
can enhance the immune response to vaccination.  In one of the earliest studies, Blecha and 
colleagues investigated the effects of various stressors on the cell-mediated responses to 2, 4-
dinitro-1-1flurobenzene (DNFB) and SRBC (Blecha et al. 1982a).  Cell mediated responses were 
determined by measuring the delayed type hypersensitivity (DTH) response.  This involves an 
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initial sensitisation by dermal administration of antigen, followed 6 days later by antigenic 
challenge, which is the re-administration of the antigen to the derma of the earlobe.  The extent of 
the response is then determined by measuring pinna thickness.  Results indicated that three 
different types of whole-body stress (immobilisation, cold-stress, and heat-stress) administered at 
close temporal proximity to the DNFB challenge all enhanced the DTH responses.  Subsequent to 
this study, a number of studies have demonstrated similar findings.  Indeed, in the first of a 
number of studies conducted by Dhabhar, McEwen and colleagues, it was shown that rats 
previously exposed to DNFB showed enhanced DTH responses when administered at the same 
time as exposure to restraint stress (Dhabhar et al. 1996).   
 
Mechanistically, it is hypothesised that the acute stress-induced enhancement of cell-mediated 
responses is associated with the rapid and robust leukocytosis observed during acute stress 
(Dhabhar and McEwen, 1996) and exercise (Kruger and Mooren, 2007).  This leukocytosis is 
driven by the rapid release of adrenaline during stress; leukocytes with a high density expression 
of adrenergic receptors on their cell surfaces, such as natural killer cells and cytotoxic 
lymphocytes, are preferentially mobilised (Anane et al. 2009; Campbell et al. 2009; Kruger et al. 
2008).  It has been hypothesised that a greater availability of these cells may enhance cell-
mediated responses upon antigenic challenge (Dhabhar, 2002).  In order to explain this 
hypothesis, Dhabhar, McEwan and colleagues utilised a military metaphor.  They suggest that the 
initial leukocytosis observed during stress represented the organism’s ‘soldiers’ (blood 
leukocytes) leaving the ‘barracks’ (spleen, lymph nodes) where they are typically located, and 
navigate the ‘boulevards’ (peripheral vasculature) to patrol, ready for action.  They hypothesise 
that the frequently observed decrease in lymphocytes to below baseline levels after acute stress 
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represents a recruitment of leukocytes to potential ‘battle stations’ (skin, lymph nodes) in 
preparation for immune challenge.  This contention appears to be supported by previous work by 
that group.  Indeed, Dhabhar, McEwan and colleagues have shown that the intensity of the stress 
was positively correlated with the DTH response to DNFB; as more intense stress induces a 
greater release of adrenaline, and concomitant redistribution of leukocytes (Dhabhar et al. 2000), 
this observation is consistent with the hypothesis that these changes may be underpinning the 
improved cell-mediated responses. Further, the duration of the stress did not appear to be 
associated with response.   In this study, rats exposed to the ‘New York City Subway Stress’ 
(restraint stress and shaking for 2 hours) exhibited higher DTH responses than rats exposed to 
more moderate stress (restraint stress for 2 hours) (Dhabhar and McEwen, 1997).  Further, more 
direct evidence in favour of this mechanism was presented in another study; it was shown that 
adrenalectomy, which eliminates the acute-stress release of adrenaline and cortisol, abolished the 
acute-stress enhancement of DTH responses (Dhabhar and McEwen, 1999).  In a more recent 
study investigating the effects of long and short days of light cycles on DTH responses in 
hamsters, it was found that DTH responses were enhanced in males exposed to short-days 
compared with long-days; but not females.  Furthermore, acute stress significantly augmented 
DTH compared with non-stressed hamsters in short-day males only.  Short-day males exhibited 
higher levels of cortisol, and it was hypothesised that the elevated DTH responses was associated 
with the HPA-axis (Bilbo and Nelson, 2003).   
 
It has also been proposed that IFN- γ could be a possible mediator of stress-induced enhancement 
of cellular responses to vaccination.  Indeed, results indicated that both immuno-neutralisation 
and gene knockout of IFN-γ eliminated the enhancement by restraint stress of the DTH response 
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(Dhabhar et al. 2000).  IFN-γ is an important cytokine involved in many aspects of the early 
stages of immune responses, by increasing antigen presentation to macrophages, promoting the 
migration of leukocytes, and activating APCs (Schroder et al. 2004).  This novel finding by 
Dhabhar, McEwan and colleagues therefore adds support to the contention that acute stress 
augments the immune system at the early stages of immune responses.  The idea that acute stress 
augments early immune interactions was also supported in a study by Saint-Mezard and 
colleagues, where it was found that acute restraint stress enhanced the DTH response to DNFB 
via direct adjuvant effects on the function of dendritic cells in vivo.  They showed that stress 
induced release of noradrenaline exerted an adjuvant effect on dendritic cells by promoting 
enhanced migration to lymph nodes.  This enhanced CD8 T cell priming, resulted in an 
enhancement of primary responses.  Further, it was demonstrated that acute stress could also 
enhance the response to a secondary antigen exposure; this may be the result of enhanced 
recruitment of CD8 T cells in the skin upon DNFB re-challenge (Saint-Mezard et al. 2003). 
 
In summary, the animal literature provides sound evidence to suggest that acute-stress may 
enhance both cell-mediated and antibody responses to vaccination.  Although the mechanisms 
underlying these adjuvant effects remain unclear, there is preliminary evidence to suggest that 
augmentation of responses occurs as a result of enhanced antigenic-surveillance, antigen-
detection and presentation.   
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ACUTE STRESS-INDUCED ENHANCEMENT OF VACCINATION RESPONSES:  
EVIDENCE FROM HUMANS 
 
Acute stress-induced enhancement of vaccination response in humans:  humoral immunity 
 
There is accumulating evidence that acute stress may also enhance immunity in humans.  Two 
early studies were conducted to investigate the apparently immuno-suppressive effects of 
exercise on immune function (Bruunsgaard et al. 1997b; Eskola et al. 1978).  These studies were 
based on the ‘open window hypothesis’ which suggests that, after a single bout of acute strenuous 
and prolonged exercise, the immune system becomes suppressed and vulnerable to infections 
such as upper respiratory tract infections (Nieman, 1995; Peters and Bateman, 1983).  The first of 
these studies found, contrary to their hypothesis, that the antibody response to tetanus toxoid 
vaccination was higher in the group who had completed a marathon, compared with a non-runner 
control group (Eskola et al. 1978).  In contrast, Bruunsgaard and colleagues found no difference 
in the antibody responses to responses to diphtheria, tetanus toxoid and 6 pneumococcal 
serotypes between triathletes who had just completed a half-ironman competition prior to 
vaccination compared with either resting triathletes or sedentary controls (Bruunsgaard et al. 
1997b).  However, although these studies utilised extreme bouts of exercise to elicit an effect of 
exercise on vaccine responses, the sample size was relatively small and did not control the exact 
duration and relative intensity of the acute stress exposure in each participant.  In other studies, 
there appears to be evidence showing that acute stress, experienced around the time of 
vaccination, may augment responses.  A study by Burns and colleagues demonstrated that higher 
levels of self-reported naturalistic stress around the time of vaccination were associated with 
enhanced antibody responses to influenza vaccination (Burns et al. 2003).  Similarly, Petry and 
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colleagues found that higher levels of negatively perceived stress during the induction phase of 
immunisation were significantly associated with higher peak anti-hepatitis B antibody titres 
(Petry et al. 1991).  However, these findings were not replicated by Smith and colleagues who 
found no association between acute psychological stress and antibody responses to KLH 
inoculation (Smith et al. 2004).    
 
More recently, a number of more controlled studies have demonstrated that acute stress may 
enhance the immune response to vaccination.  A number of studies by Edwards and colleagues 
have demonstrated that both acute exercise and psychological stress experienced at close 
temporal proximity to vaccination have a beneficial effect on the subsequent antibody response.  
The first of these studies investigated whether humoral responses to a thymus-dependent 
(influenza) and thymus-independent (meningococcal) vaccine were affected by acute dynamic 
(cycling) exercise or psychological stress.  Participants in the exercise group completed a cycling 
task at 55 % of Watt Max*, those in the psychological stress group completed a time-pressured 
mental arithmetic test, and a non-stress control group rested quietly.  Following their allotted 45 
min task, participants received an influenza vaccine.  Results indicated that women in both the 
exercise group and psychological stress groups showed enhanced antibody responses to the 
A/Panama influenza strain at 4 and 20 weeks post-vaccination, in comparison to the resting 
control group (Edwards et al. 2006a).  This strain elicited particularly poor antibody responses in 
the female control group, suggesting that the interventions successfully augmented the antibody 
response to an otherwise weakly-immunogenic strain.  In contrast, men displayed robust 
responses to all strains, and no effects of exercise or stress were observed.  In the same study 
(Edwards et al. 2008), participants were also administered a meningococcal A + C vaccine into 
*   Watt max = Maximal workload in Watts 
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the contralateral arm.  Results indicated that, in men, both exercise and psychological stress 
improved the antibody response to meningococcal A in men, compared with control men.  In 
agreement with the previous study, augmentation was observed where the control group response 
was poor; on this occasion, men, rather than women, in the control group had weaker responses 
to this particular strain.  These results confirmed that the adjuvant effects of exercise and 
psychological stress are not limited to thymus-dependent (e.g., influenza) or thymus-independent 
(e.g., meningococcal) vaccines, and thus do not seem to be dependent on T cell interactions. 
  
In the final study in this series by Edwards and colleagues, a resistance-based, eccentric exercise 
protocol was developed (Edwards et al. 2007a).  An eccentric exercise task was designed to 
initiate a local inflammatory response in the biceps brachialis and deltoid muscles of the arm in 
which the influenza vaccine was administered.  It was hypothesised that this inflamed local 
environment provides an efficient way of augmenting the antibody response to influenza 
vaccination.  Sixty healthy young adults (31 men, 29 women) were randomly allocated to either 
an eccentric exercise group or a control group.  The exercise group performed 50 repetitions of 
the eccentric portion of the bicep curl and lateral raise exercises in the non-dominant arm; the 
task lasted approximately 25 minutes.  The control group rested quietly for the same time.  Six 
hours after task completion, allowing for the inflammatory response to the exercise to develop 
(i.e., IL-6; MacIntyre et al. 2001), participants received an influenza vaccine into the non-
dominant arm.  Results indicated that women in the exercise group showed enhanced antibody 
responses to the A/Wyoming and B/Jiangsu strains of influenza at 6 and 20 weeks post-
vaccination.  Again, these strains had produced relatively weak antibody responses in women in 
the control group; again, however, men showed more robust responses against these strains and 
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no effects of exercise were found.  In line with these findings, the other strain in the vaccine, 
A/New Caledonia, produced robust responses in both men and women in the control group and 
no effect of exercise was observed. 
 
Acute stress-induced enhancement of vaccination response in humans:  cellular immunity 
 
Only two studies have investigated the effects of acute stress on cell-mediated responses to 
vaccination.  The first of these studies was conducted by Smith and colleagues, who examined 
the extent of the DTH response to KLH inoculation in participants immediately after a viva voce 
examination.  Results indicated that self-reported distress at the time of vaccination was 
negatively correlated with the likelihood of developing a DTH response (Smith et al. 2004). 
These findings contrast with a more recent, highly controlled study conducted by Edwards and 
colleagues who investigated the effects of eccentric arm exercise on the cell-mediated response to 
influenza vaccination.  In this study, cell-mediated responses were measured indirectly by 
quantifying the whole blood antigen-specific interferon-γ response to stimulation with the 
influenza vaccine in vitro at 28 days post-vaccination (Edwards et al. 2007a).  Results indicated 
that men in the exercise group exhibited higher IFN-γ responses to the vaccine at this time point, 
in comparison to resting controls.  These findings suggest that further research investigating the 
role of behavioural stressors on cell-mediated immune responses in humans is warranted. 
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ECCENTRIC EXERCISE AS A BEHAVIOURAL ADJUVANT TO VACCINATION 
 
During an active eccentric muscle action, the exercising muscle applies force as it lengthens, 
causing damage to the internal structure of the muscle fibres (Proske and Morgan, 2001).  This 
damage is greater than that observed with concentric (shortening) muscle contractions (Sorichter 
et al. 1999) and, in untrained individuals when substantial damage is caused, leads to an 
inflammatory response in the muscle (Sorichter et al. 2006).  Characterised by oedema, muscle 
pain, muscle weakness, leakage of muscle and cellular proteins (e.g., CK), and cellular 
infiltration, this response occurs early post-injury and may last anything up to 2 – 7 days (Peake 
et al. 2005).  For example, exercise elevates the levels of inflammatory mediators released from 
stressed cells within the damaged muscle tissue (Peake et al. 2005).  These stressed cells release a 
range of danger signals, such as IL-6, uric acid, HSP60, HSP70, and are thought to play a role in 
orchestrating inflammation and repair of the surrounding tissues (Hirose et al. 2004; Matzinger, 
2002; Peake et al. 2005).  Therefore, it possible that eccentric exercise, performed using the 
muscles located at the site of vaccine administration, improves the subsequent immune response 
by inducing a pro-inflammatory environment in the muscles.  In support of this theory, the extent 
of the self-reported pain and the change in upper arm limb circumference following eccentric 
exercise, both indirect indicators of muscle damage, have been significantly positively correlated 
with the subsequent cell mediated immune response to the vaccination (Edwards et al. 2007a). 
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OPTIMISATION OF ECCENTRIC EXERCISE AS AN ADJUVANT TO VACCINATION 
 
Given the relatively poor immunogenicity of many current vaccines, there is a renewed desire to 
identify novel, safe and easily applicable strategies to improve immune responses.  Further, 
research now supports the contention that acute behavioural stress, in the form of eccentric 
exercise, may offer a realistic and efficacious means of doing this.  Eccentric exercise has many 
advantages as an adjuvant:  it is inexpensive (i.e., equipment costs are low); it is easily 
administered (i.e., simple training and little equipment required); it only takes a relatively short 
time to carry-out (i.e., 25 minutes); and most importantly, the potential health risks associated 
with it are low.   Although rigorous investigation into the clinical use of eccentric exercise would 
be required, it is likely that the intervention could be implemented relatively quickly.  On the 
other hand, exogenous adjuvants have to undergo lengthy periods of testing before they are 
approved for public use.  For example, clinical trials can take up to 8 years to complete (World 
Health Organisation; http://www.who.int), and that does not include the time it takes to firstly 
discover, purify and test the original adjuvant in the laboratory.  Given this, investigation into the 
use of eccentric exercise as an adjuvant to vaccination is warranted, and particular attention is 
needed into determining the optimal intervention protocol.  In order to do this, a number of 
considerations have yet to be investigated:  the optimal timing of vaccine administration after 
exercise; the minimal intensity of exercise needed to elucidate an adjuvant effect; and the ideal 
site of vaccine administration after eccentric exercise. 
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Issue of exercise timing prior to vaccination 
 
In response to eccentric exercise-induced muscle damage, a complex inflammatory cascade is 
induced.  Various markers of inflammation peak at different time points, with some commencing 
almost immediately after the onset of muscle damage, and others occurring more slowly but 
lasting up to 7 days post-exercise (Peake et al. 2005).  Manipulating the timing of the vaccination 
relative to the exercise may, therefore, allow the optimization of the intervention by coinciding 
the vaccination with a particularly potent inflammatory response.  Further, this approach also 
allows the indirect investigation of mechanisms, by coinciding the vaccination with post-exercise 
peaks in different potential mediators.   
 
Vaccination at six hours post-exercise:  role of IL-6 
 
In a previous study, an augmented vaccine response was successfully induced using a protocol in 
which participants were vaccinated immediately post-cycling exercise (Edwards et al. 2006a).  In 
this study, Edwards and colleagues examined the relationship between the IL-6 responses to 
acute stress and the antibody responses to vaccination.  Using hierarchical linear regression 
analysis, which controlled for baseline antibody titres, they revealed that IL-6 concentrations at 
60 minutes after stress exposure (cycling and / or arithmetic test) positively predicted the 
antibody response to the A/Panama strain of influenza, which was the only strain responsive to 
cycling exercise (Edwards et al. 2006a).  In a further study conducted by Edwards and 
colleagues, the immune response to influenza vaccination was enhanced when the vaccine was 
administered 6 hr post-eccentric exercise (Edwards et al. 2007a).  This timepoint was selected to 
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coincide with the peak blood plasma response of the cytokine interleukin-6 (IL-6) to eccentric 
exercise (MacIntyre et al. 2001).  In response to eccentric exercise, it has been proposed that IL-6 
release derived specifically from damaged myocytes in the skeletal muscle (Bruunsgaard et al. 
1997a; Febbraio and Pedersen, 2002).  Given that eccentric exercise induces the greatest degree 
of muscle damage – compared with other modes of exercise – it is interesting to consider the 
effects of muscle damage and concomitant IL-6 release on the immune response to vaccination.  
Unfortunately, IL-6 was not measured in this study, and no associations could be made between 
the IL-6 response to exercise and the immune response to the vaccine (Edwards et al. 2007a).   
 
Combined, the findings from these two human studies lend support to the hypothesis that 
elevated plasma IL-6 may enhance vaccine responses.  There is also supportive data from a 
number of clinical studies measuring IL-6 as an adjuvant to vaccination.  Generally speaking, the 
IL-6 response to physical and psychological stress is thought to mimic the immunological 
responses observed during clinical stressors such as surgery, trauma and sepsis (Heinrich et al. 
1990).  High levels of IL-6 are associated with stronger antibody responses to live Francisella 
tularensis vaccination in humans (Krakauer 1995) and co-administration of plasmids encoding 
IL-6 has been shown to enhance influenza vaccine efficacy in mice (Krakauer, 1995; Lee et al. 
1999).  Further, there is preliminary evidence that IL-6, co-administered with vaccine, can 
enhance the immune response to malaria vaccination (Hui and Hashimoto, 2007), and can 
improve the humoral response against ovarian cancer cells (Reinartz et al. 2003).  For these 
reasons, the IL-6 response to eccentric exercise, and its associations with the antibody response to 
vaccination will be assessed in Chapter Two and Chapter Three in this thesis. 
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From a pragmatic perspective, vaccination at six hours post-exercise is not the most ideal strategy 
for clinical application of eccentric exercise as this approach requires the participant to visit the 
laboratory or clinic twice in the same day.  For this reason, it is important to consider whether 
vaccinating immediately after eccentric exercise enhances the immune response to vaccination. 
 
Vaccination immediately post-exercise 
 
Vaccination immediately post-exercise would simplify any future clinical application of this 
intervention; participants would only have to visit the laboratory on one occasion to complete the 
exercise task and to receive the vaccine.  There are also sound theoretical reasons to hypothesise 
that this might be an effective timepoint for enhancing immune responses to vaccination.  The 
high physical demands of physical stress result in the activation of a fight-or-flight response  
(Cannon, 1932), and promote survival by activating a number of defence mechanisms within the 
body.  The acute stress response is characterised by a rapid and robust discharge of the 
sympathetic nervous system (SNS) which results in the release of catecholamines (e.g., 
adrenaline and noradrenaline) leading to a concomitant elevation in heart rate, blood pressure and 
respiration (Elenkov et al. 2000; Goldstein, 2003).  Also activated during acute stress is the 
hypothalamic-pituitary-adrenal (HPA) axis, which leads to the subsequent release of cytokines 
causing mild inflammation (Black, 2002).  As both the SNS and HPA axis are activated by 
exercise, and can influence immune function, they are both plausible mechanisms that may 
underpin the acute stress enhancement phenomenon.  Studies investigating the effects of cortisol, 
released during acute stress, on the immune response to vaccination have produced inconsistent 
and often contrasting results.  For example, in a study by Dhabhar, McEwan and colleagues, it 
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was demonstrated that DTH responses enhanced by acute-stress were impaired by 
adrenalectomy, and restored by exogenous corticosterone administration (Dhabhar and McEwen, 
1999).  These findings were not replicated however in a study by Blecha and colleagues who 
suggested that DTH responses were suppressed by elevated levels of corticosterone (Blecha et al. 
1982b).  In addition to cell-mediated responses, there appears to be mixed results regarding the 
effects of cortisol levels on antibody responses to vaccination.  For example, it has been 
demonstrated that elevated glucocorticoid levels, induced by cocaine administration, were 
associated with an augmented antibody response to SRBC inoculation (Stanulis et al. 1997).  
However, Edwards and colleagues investigated the role of cortisol and the effects of acute stress 
on vaccination responses to influenza vaccine in humans.  The extent of the cortisol response to 
cycling exercise and / or psychological stress was not associated with the antibody responses to 
any of the three viral strains of influenza (Edwards et al. 2006a).  The exercise bout used in that 
study was performed at 55 % Watt max, and there is research to suggest that the exercise bout 
needs to be higher than 60% to elicit an increase in plasma cortisol (Galbo et al. 1981).  However, 
given the results of Edwards and colleagues, it seems unlikely that cortisol is the primary 
mechanism underpinning the immuno-enhancement seen in response to the acute physical and 
psychological stress enhancement of vaccine responses in humans.   
 
Activation of the sympathetic nervous system also leads to the release of adrenaline that has a 
direct effect on immune cells (Elenkov et al. 2000; Goldstein, 2003).  It is thought that these 
effects may directly impact the immune response to vaccination (Dhabhar, 2002).  Indeed, 
Dhabhar, McEwan and colleagues have shown that adrenaline administration resulted in a dose-
dependent augmentation of DTH responses to DNFB in treated animals compared with controls.  
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Recent research suggests that adrenaline mobilises leukocytes exhibiting effector phenotypes and 
the unique capability to migrate to damaged tissues (Campbell et al. 2009; Miller, 2004).  It is 
possible that a re-distribution of these cells to sites of muscle damage may provide a mechanism 
for enhanced vaccine responses.   
 
In Chapter Two of this thesis, participants were vaccinated immediately after exercise to 
investigate the efficacy of vaccinating at this timepoint.  If vaccination responses are improved at 
this timepoint, then a role of adrenaline and / or cortisol, and subsequent leukocyte infiltration, 
may be supported.   
 
Vaccination at 48 hours post-exercise 
 
Peak muscle damage, defined by pain, swelling, loss of muscle function and the release of muscle 
cytosolic enzymes such as creatine kinase into the circulation, is delayed and typically does not 
peak for days after exercise cessation (Sorichter et al. 1999).  Indeed, at approximately 48 hr 
post-exercise, there is a peak accumulation of inflammatory infiltrate comprised of cellular (e.g. 
neutrophils and mononuclear cells; (Fielding et al. 1993) and secreted (e.g. cytokines, heat shock 
proteins, uric acid (Peake et al. 2005) factors.  For example, this timepoint may coincide with a 
peak in number of macrophages in a pro-inflammatory state in the damaged muscle that may 
dually assist in antigen recognition and clearance, before reverting to an anti-inflammatory state 
after viral clearance (Chazaud et al. 2009).  Although vaccination at this timepoint would not 
offer the most pragmatic approach for implementing eccentric exercise in a clinical setting, it is 
possible that the heightened inflammatory environment at this time may be particularly effective 
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at enhancing antigenic recognition and clearance at the site of muscle damage.  At present, no 
studies have investigated this approach in humans, and for this reason, the immune response to 
vaccination when administered at 48 hours post-exercise will be measured in Chapter Two in this 
thesis.  
 
Issue of eccentric exercise intensity 
 
Before eccentric exercise can be implemented in a clinical setting, further research is also needed 
to establish the optimal intensity of eccentric exercise.  In the only prior study investigating 
eccentric exercise on the immune response to vaccination, Edwards and colleagues found 
beneficial effects when eccentric arm exercise was conducted at 85 % of 1RM.  This is an 
intensity that had been shown to elicit the desired inflammatory responses (Edwards et al. 2007a).  
Despite the overall success of this intervention, the intensity that was chosen has not been 
compared with other intensities of exercise; it is not clear whether a lesser intensity would 
achieve similar enhancement of vaccine responses.  A lesser intensity of exercise would enable a 
more acceptable and safer intervention approach.   
 
Issue of vaccination site following eccentric exercise 
 
Before eccentric exercise as an adjuvant to vaccination can be adopted, the optimal site of 
vaccine administration must be identified.  In a prior eccentric exercise and vaccination study, 
Edwards and colleagues found an adjuvant effect of exercise when the vaccine was administered 
into exercised muscle tissue.  However, it is not clear whether this adjuvant effect would have 
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been achieved had the vaccine been administered into non-exercised muscle tissue, following 
eccentric exercise.  Indeed, there are sound theoretical reasons to suggest that vaccine responses 
may be enhanced in both circumstances.   
 
Locally, unaccustomed eccentric exercise causes muscle damage and induces an inflammatory 
response in the muscle characterised by oedema, pain and increased immunological activity 
(Peake et al. 2005).  In particular, the release of immunological danger signals can activate 
dendritic cells (Gallucci et al. 1999; Shi and Rock, 2002) and animal research has shown that this 
can lead to enhanced antigenic transport and presentation in lymph nodes, leading to a heightened 
antigen-specific response from CD8+ T cells (Saint-Mezard et al. 2003).  On the other hand, 
eccentric exercise also induces a number of systemic alterations which could lead to an 
augmented antibody response to vaccination.  For example, during this type of exercise, it has 
been demonstrated that circulating levels of inflammatory mediators, such as plasma IL-6 (Peake 
et al. 2005) are elevated above resting levels.  It is possible that increased levels of these pro-
inflammatory mediators in the systemic circulation, stemming from eccentric exercise-induced 
muscle damage, could be a mechanism for augmented immune responses seen previously 
(Edwards et al. 2007a).  By comparing the antibody responses of exercised participants who 
received their vaccine into either the exercised or the resting arm, it is possible to determine the 
optimal site of vaccination and to begin to elucidate some of the underlying mechanisms.   
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SUMMARY AND OVERVIEW OF THESIS 
 
This thesis comprises three large experimental studies and each of these investigated the effects 
of eccentric exercise on the immune response to vaccination in humans.  The eccentric exercise 
protocol was employed to induce muscle damage to the biceps brachialis and deltoid muscles of 
the non-dominant arm, which is known to cause a local inflammatory response, and can lead to 
enhanced vaccine responses (Edwards et al. 2007a). 
 
The first study (Chapter Two) investigated the effect of exercise timing on the efficacy of the 
immune response to influenza vaccination.  Eccentric exercise was performed either immediately, 
6 hours or 48 hours prior to influenza vaccination, and the immune responses of these groups 
were compared with a non-exercise control group.  Immune responses were measured by 
antibody titres and in vitro cell-mediated responses to the whole vaccine at 28 days post-
vaccination.   
 
The second study (Chapter Three) investigated the influence of exercise intensity on the efficacy 
of the immune response to influenza vaccination.  Eccentric exercise was performed at 60 %, 85 
% or 110 % of 1RM to determine whether the degree of exercise induced muscle damage and 
concomitant inflammation affected the subsequent immune response.  Exercise was performed 
immediately prior to influenza vaccination, and antibody titres were compared with the responses 
of a non-exercise control group at 28 days post-vaccination.   
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The final study in this thesis (Chapter Four) investigated whether the site of vaccination affects 
the efficacy of the eccentric exercise intervention.  In this study, a comparison is made between 
exercise participants who receive a vaccine directly into eccentrically-exercised damaged muscle 
tissue, or exercise participants who receive the vaccine into the non-exercised arm.  Further, 
Chapter Four investigates whether the immune response to a relatively poor immunogenic 
vaccine, hepatitis B, is enhanced by eccentric exercise.  Immune responses were measured by 
antibody titres and in vitro cell-mediated responses to the whole vaccine.   
 
In sum, this programme of research was conducted to extend our understanding of the use of 
eccentric exercise as an adjuvant to vaccination.  The studies were designed to identify the 
optimal intervention strategy in healthy young adults, in order to develop an evidence-based 
protocol for use in other, more vulnerable, populations.  Each study was also designed to allow 
some investigation of the mechanisms underpinning this effect.  
  
 34 
REFERENCES 
 
 
Aguilar, J.C. , Rodriguez, E.G., 2007. Vaccine adjuvants revisited. Vaccine 25, 3752-3762. 
Anane, L.H., Edwards, K.M., Burns, V.E., Drayson, M.T., Riddell, N.E., Veldhuijzen van 
Zanten, J.J., Wallace, G., Mills, P.J., Bosch, J.A., in press. Mobilization of gammadelta T 
lymphocytes in response to psychological stress, exercise, and beta-agonist infusion. Brain 
Behav. Immun. 
 
Bilbo, S.D. , Nelson, R.J., 2003. Sex differences in photoperiodic and stress-induced 
enhancement of immune function in Siberian hamsters. Brain Behav. Immun. 17, 462-472. 
 
Black, P.H., 2002. Stress and the inflammatory response: a review of neurogenic inflammation. 
Brain Behav. Immun. 16, 622-653. 
 
Blecha, F., Barry, R.A., Kelley, K.W., 1982a. Stress-induced alterations in delayed-type 
hypersensitivity to SRBC and contact sensitivity to DNFB in mice. Proc. Soc. Exp. Biol. Med. 
169, 239-246. 
 
Blecha, F., Kelley, K.W., Satterlee, D.G., 1982b. Adrenal involvement in the expression of 
delayed-type hypersensitivity to SRBC and contact sensitivity to DNFB in stressed mice. Proc. 
Soc. Exp. Biol. Med. 169, 247-252. 
 
Bruunsgaard, H., Galbo, H., Halkjaer-Kristensen, J., Johansen, T.L., MacLean, D.A., Pedersen, 
B.K., 1997a. Exercise-induced increase in serum interleukin-6 in humans is related to muscle 
damage. J. Physiol 499 ( Pt 3), 833-841. 
 
 35 
Bruunsgaard, H., Hartkopp, A., Mohr, T., Konradsen, H., Heron, I., Mordhorst, C.H., Pedersen, 
B.K., 1997b. In vivo cell-mediated immunity and vaccination response following prolonged, 
intense exercise. Med. Sci. Sports Exerc. 29, 1176-1181. 
Burns, V.E., Carroll, D., Drayson, M., Whitham, M., Ring, C., 2003. Life events, perceived stress 
and antibody response to influenza vaccination in young, healthy adults. J. Psychosom. Res. 55, 
569-572. 
 
Campbell, J.P., Riddell, N.E., Burns, V.E., Turner, M., van Zanten, J.J., Drayson, M.T., Bosch, 
J.A., 2009. Acute exercise mobilises CD8+ T lymphocytes exhibiting an effector-memory 
phenotype. Brain Behav. Immun. 23, 767-775. 
 
Cannon, W.B., 1932. The wisdom of the body. Norton, New York, NY.  
Chazaud, B., Brigitte, M., Yacoub-Youssef, H., Arnold, L., Gherardi, R., Sonnet, C., Lafuste, P., 
Chretien, F.,  2009.  Dual and beneficial roles of macrophages during skeletal muscle 
regeneration.  Ex. Sport Sci. Rev. 1, 18-22. 
Dhabhar, F.S., 2002. Stress-induced augmentation of immune function--the role of stress 
hormones, leukocyte trafficking, and cytokines. Brain Behav. Immun. 16, 785-798. 
Dhabhar, F.S. , McEwen, B.S., 1996. Stress-induced enhancement of antigen-specific cell-
mediated immunity. J. Immunol. 156, 2608-2615. 
Dhabhar, F.S., McEwen, B.S., 1997. Acute stress enhances while chronic stress suppresses cell-
mediated immunity in vivo: a potential role for leukocyte trafficking. Brain Behav. Immun. 11, 
286-306. 
Dhabhar, F.S. , McEwen, B.S., 1999. Enhancing versus suppressive effects of stress hormones on 
skin immune function. Proc. Natl. Acad. Sci. U. S. A 96, 1059-1064. 
 36 
Dhabhar, F.S., Miller, A.H., McEwen, B.S., Spencer, R.L., 1996. Stress-induced changes in 
blood leukocyte distribution. Role of adrenal steroid hormones. J. Immunol. 157, 1638-1644. 
Dhabhar, F.S., Satoskar, A.R., Bluethmann, H., David, J.R., McEwen, B.S., 2000. Stress-induced 
enhancement of skin immune function: A role for gamma interferon. Proc. Natl. Acad. Sci. U. S. 
A 97, 2846-2851. 
Edwards, K.M., Burns, V.E., Adkins, A.E., Carroll, D., Drayson, M., Ring, C., 2008. 
Meningococcal A vaccination response is enhanced by acute stress in men. Psychosom. Med. 70, 
147-151. 
Edwards, K.M., Burns, V.E., Allen, L.M., McPhee, J.S., Bosch, J.A., Carroll, D., Drayson, M., 
Ring, C., 2007a. Eccentric exercise as an adjuvant to influenza vaccination in humans. Brain 
Behav. Immun. 21, 209-217. 
Edwards, K.M., Burns, V.E., Carroll, D., Drayson, M., Ring, C., 2007b. The acute stress-induced 
immunoenhancement hypothesis. Exerc. Sport Sci. Rev. 35, 150-155. 
Edwards, K.M., Burns, V.E., Reynolds, T., Carroll, D., Drayson, M., Ring, C., 2006a. Acute 
stress exposure prior to influenza vaccination enhances antibody response in women. Brain 
Behav. Immun. 20, 159-168. 
Edwards, K.M., Burns, V.E., Ring, C., Carroll, D., 2006b. Individual differences in the 
interleukin-6 response to maximal and submaximal exercise tasks. J. Sports Sci. 24, 855-862. 
Elenkov, I.J., Wilder, R.L., Chrousos, G.P., Vizi, E.S., 2000. The sympathetic nerve--an 
integrative interface between two supersystems: the brain and the immune system. Pharmacol. 
Rev. 52, 595-638. 
 37 
Eskola, J., Ruuskanen, O., Soppi, E., Viljanen, M.K., Jarvinen, M., Toivonen, H., Kouvalainen, 
K., 1978. Effect of sport stress on lymphocyte transformation and antibody formation. Clin. Exp. 
Immunol. 32, 339-345. 
Febbraio, M.A. , Pedersen, B.K., 2002. Muscle-derived interleukin-6: mechanisms for activation 
and possible biological roles. FASEB J. 16, 1335-1347. 
 
Fielding, R.A., Manfredi, T.J., Ding, W., Fiatarone, M.A., Evans, W.J., Cannon, J.G., 1993. 
Acute phase response in exercise. III. Neutrophil and IL-1 beta accumulation in skeletal muscle. 
Am. J. Physiol 265, R166-R172. 
Galbo, H., Christensen, N.J., Mikines, K. J., Sonne, B., Hilsted, J., Hagen, C., Fahrenkrug, J.  
1981.  The Effect of Fasting on the Hormonal Response to Graded Exercise.  J. Clin. Endocrin. 
Met. 52 (6) 1106-1112. 
Gallucci, S., Lolkema, M., Matzinger, P., 1999. Natural adjuvants: endogenous activators of 
dendritic cells. Nat. Med. 5, 1249-1255. 
Gazda, L.S., Smith, T., Watkins, L.R., Maier, S.F., Fleshner, M., 2003. Stressor exposure 
produces long-term reductions in antigen-specific T and B cell responses. Stress. 6, 259-267. 
Glavin, G.B., Pare, W.P., Sandbak, T., Bakke, H.K., Murison, R., 1994. Restraint stress in 
biomedical research: an update. Neurosci. Biobehav. Rev. 18, 223-249. 
 
Goldstein, D.S., 2003. Catecholamines and stress. Endocr. Regul. 37, 69-80. 
 
Heinrich, P.C., Castell, J.V., Andus, T., 1990. Interleukin-6 and the acute phase response. 
Biochem. J. 265, 621-636. 
 
Hilleman, M.R., 2000. Vaccines in historic evolution and perspective: a narrative of vaccine 
discoveries. Vaccine 18, 1436-1447. 
 38 
 
Hirose, L., Nosaka, K., Newton, M., Laveder, A., Kano, M., Peake, J., Suzuki, K., 2004. Changes 
in inflammatory mediators following eccentric exercise of the elbow flexors. Exerc. Immunol. 
Rev. 10, 75-90. 
Hui, G. , Hashimoto, C., 2007. Interleukin-6 has differential influence on the ability of adjuvant 
formulations to potentiate antibody responses to a Plasmodium falciparum blood-stage vaccine. 
Vaccine 25, 6598-6603. 
 
Janeway, C.A., Jr., 1989. Approaching the asymptote? Evolution and revolution in immunology. 
Cold Spring Harb. Symp. Quant. Biol. 54 Pt 1, 1-13. 
 
Kapasi, Z.F., Catlin, P.A., Joyner, D.R., Lewis, M.L., Schwartz, A.L., Townsend, E.L., 2000. The 
effects of intense physical exercise on secondary antibody response in young and old mice. Phys. 
Ther. 80, 1076-1086. 
 
Karp, J.D., Smith, J., Hawk, K., 2000. Restraint stress augments antibody production in 
cyclophosphamide-treated mice. Physiol Behav. 70, 271-278. 
 
Krakauer, T., 1995. Levels of interleukin 6 and tumor necrosis factor in serum from humans 
vaccinated with live, attenuated Francisella tularensis. Clin. Diagn. Lab Immunol. 2, 487-488. 
 
Kruger, K., Lechtermann, A., Fobker, M., Volker, K., Mooren, F.C., 2008. Exercise-induced 
redistribution of T lymphocytes is regulated by adrenergic mechanisms. Brain Behav. Immun. 22, 
324-338. 
Kruger, K. , Mooren, F.C., 2007. T cell homing and exercise. Exerc. Immunol. Rev. 13, 37-54. 
 39 
Laudenslager, M.L., Fleshner, M., Hofstadter, P., Held, P.E., Simons, L., Maier, S.F., 1988. 
Suppression of specific antibody production by inescapable shock: stability under varying 
conditions. Brain Behav. Immun. 2, 92-101. 
Lee, S.W., Youn, J.W., Seong, B.L., Sung, Y.C., 1999. IL-6 induces long-term protective 
immunity against a lethal challenge of influenza virus. Vaccine 17, 490-496. 
 
MacIntyre, D.L., Sorichter, S., Mair, J., Berg, A., McKenzie, D.C., 2001. Markers of 
inflammation and myofibrillar proteins following eccentric exercise in humans. Eur. J. Appl. 
Physiol 84, 180-186. 
Matzinger, P., 2002. The danger model: a renewed sense of self. Science 296, 301-305. 
 
Millan, S., Gonzalez-Quijano, M.I., Giordano, M., Soto, L., Martin, A.I., Lopez-Calderon, A., 
1996. Short and long restraint differentially affect humoral and cellular immune functions. Life 
Sci. 59, 1431-1442. 
 
Miller, J.A.L., 2004. The nature and formation of muscle inflammation after eccentric exercise 
damage and in polymyositis. University of Birmingham PhD Thesis, Birmingham, UK,  
Nicholson, K.G., Wood, J.M., Zambon, M., 2003. Influenza. Lancet 362, 1733-1745. 
 
Nieman, D.C., 1995. Upper respiratory tract infections and exercise. Thorax 50, 1229-1231. 
 
Peake, J., Nosaka, K., Suzuki, K., 2005. Characterization of inflammatory responses to eccentric 
exercise in humans. Exerc. Immunol. Rev. 11, 64-85. 
Persoons, J.H., Berkenbosch, F., Schornagel, K., Thepen, T., Kraal, G., 1995. Increased specific 
IgE production in lungs after the induction of acute stress in rats. J. Allergy Clin. Immunol. 95, 
765-770. 
 40 
 
Peters, E.M. , Bateman, E.D., 1983. Ultramarathon running and upper respiratory tract infections. 
An epidemiological survey. S. Afr. Med. J. 64, 582-584. 
 
Petry, L.J., Weems, L.B., Livingstone, J.N., 1991. Relationship of stress, distress, and the 
immunologic response to a recombinant hepatitis B vaccine. J. Fam. Pract. 32, 481-486. 
 
Proske, U. , Morgan, D.L., 2001. Muscle damage from eccentric exercise: mechanism, 
mechanical signs, adaptation and clinical applications. J. Physiol 537, 333-345. 
Reinartz, S., Hombach, A., Kohler, S., Schlebusch, H., Wallwiener, D., Abken, H., Wagner, U., 
2003. Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral 
immune response against CA125+ (MUC-16) ovarian cancer. Cancer Res. 63, 3234-3240. 
 
Rock, K.L., Hearn, A., Chen, C.J., Shi, Y., 2005. Natural endogenous adjuvants. Springer Semin. 
Immunopathol. 26, 231-246. 
Saint-Mezard, P., Chavagnac, C., Bosset, S., Ionescu, M., Peyron, E., Kaiserlian, D., Nicolas, 
J.F., Berard, F., 2003. Psychological stress exerts an adjuvant effect on skin dendritic cell 
functions in vivo. J. Immunol. 171, 4073-4080. 
 
Schroder, K., Hertzog, P.J., Ravasi, T., Hume, D.A., 2004. Interferon-gamma: an overview of 
signals, mechanisms and functions. J. Leukoc. Biol. 75, 163-189. 
 
Shi, Y. , Rock, K.L., 2002. Cell death releases endogenous adjuvants that selectively enhance 
immune surveillance of particulate antigens. Eur. J. Immunol. 32, 155-162. 
Silberman, D.M., Wald, M.R., Genaro, A.M., 2003. Acute and chronic stress exert opposing 
effects on antibody responses associated with changes in stress hormone regulation of T-
lymphocyte reactivity. J. Neuroimmunol. 144, 53-60. 
 41 
 
Smith, A., Vollmer-Conna, U., Bennett, B., Wakefield, D., Hickie, I., Lloyd, A., 2004. The 
relationship between distress and the development of a primary immune response to a novel 
antigen. Brain Behav. Immun. 18, 65-75. 
 
Sorichter, S., Martin, M., Julius, P., Schwirtz, A., Huonker, M., Luttmann, W., Walterspacher, S., 
Berg, A., 2006. Effects of unaccustomed and accustomed exercise on the immune response in 
runners. Med. Sci. Sports Exerc. 38, 1739-1745. 
Sorichter, S., Puschendorf, B., Mair, J., 1999. Skeletal muscle injury induced by eccentric muscle 
action: muscle proteins as markers of muscle fiber injury. Exerc. Immunol. Rev. 5, 5-21. 
 
Stanulis, E.D., Matulka, R.A., Jordan, S.D., Rosecrans, J.A., Holsapple, M.P., 1997. Role of 
corticosterone in the enhancement of the antibody response after acute cocaine administration. J. 
Pharmacol. Exp. Ther. 280, 284-291. 
 
Villari, P., Manzoli, L., Boccia, A., 2004. Methodological quality of studies and patient age as 
major sources of variation in efficacy estimates of influenza vaccination in healthy adults: a 
meta-analysis. Vaccine 22, 3475-3486. 
 
Wood, P.G., Karol, M.H., Kusnecov, A.W., Rabin, B.S., 1993. Enhancement of antigen-specific 
humoral and cell-mediated immunity by electric footshock stress in rats. Brain Behav. Immun. 7, 
121-134. 
 
 
  
 42 
CHAPTER TWO 
 
THE EFFECTS OF VACCINE TIMING  
ON THE EFFICACY OF AN ACUTE ECCENTRIC EXERCISE INTERVENTION  
ON THE IMMUNE RESPONSE TO AN INFLUENZA VACCINE  
IN YOUNG ADULTS 
 
ABSTRACT 
 
An acute bout of exercise prior to vaccination can improve the antibody and cell-mediated 
responses to influenza vaccination.  The mechanisms underpinning this adjuvant effect remain 
unclear, and further investigation to determine the optimal exercise protocol is warranted.  The 
aim of the current study was to determine whether exercise augmented the immune response to 
vaccination, and whether the timing of exercise relative to vaccination affected the efficacy of the 
intervention.  One hundred and fifty six (76 men) healthy participants were randomly assigned to 
a control group or one of three intervention groups who exercised immediately, 6 hr or 48 hr 
prior to administration of a standard trivalent influenza vaccine.  The exercise groups performed 
50 repetitions of the eccentric portion of both the bicep curl and lateral raise movements at an 
intensity eliciting 85% of each participant’s pre-determined concentric one repetition maximal.  
Antigen specific serum antibody titres were measured at baseline and 28 days post-vaccination as 
indicators of the humoral response.  All three viral strains elicited strong antibody responses; 
however, eccentric exercise did not further augment any antibody responses compared with the 
control group.  Cell-mediated immunity at 28 days post-vaccination was determined by 
measuring the IFN-γ response to in vitro stimulation of the blood with whole vaccine.  There 
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were no differences in cell-mediated immunity among the groups.  Although these null findings 
were unexpected, they are consistent with previous research showing that exercise-induced 
immuno-enhancement was only observed when the control group had relatively poor responses.  
In conclusion, it is likely that the robust immune responses to the vaccine observed in this study 
may have limited any further immune enhancement by exercise. 
 
INTRODUCTION 
 
Influenza is a major cause of morbidity and mortality resulting in the death of up to half a million 
people annually worldwide (WHO Influenza Position Paper, 2005).  Vaccination is used to 
reduce the incidence of influenza infection but, as yet, is only effective at preventing illness in 
approximately two-thirds of the population (Villari et al. 2004).  Low efficacy rates have 
prompted further research into the role of adjuvants that may enhance the immune response to 
vaccination (Aguilar and Rodriguez, 2007).  In addition to the studies investigating exogenous 
adjuvants, research has begun examine the potential role of behaviourally-induced, endogenous 
adjuvants (Edwards et al. 2007b).  For example, acute stress exposure prior to immunization has 
been shown to improve both humoral (Millan et al. 1996; Persoons et al. 1995; Silberman et al. 
2003; Wood et al. 1993) and cell-mediated immunity in rodents (Blecha et al. 1982; Dhabhar and 
McEwen, 1996; Dhabhar and McEwen, 1997; Dhabhar and McEwen, 1999; Saint-Mezard et al. 
2003; Saint-Mezard et al. 2004). 
 
Adjuvant effects of acute psychological stress and exercise have also been demonstrated in 
humans (Edwards et al. 2006; Edwards et al. 2007a; Edwards et al. 2008).  For example, acute 
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stress improved the antibody response to influenza vaccination in women (Edwards et al. 2006).  
In order to maximise the potential adjuvant effect of the acute exercise intervention, a  resistance-
based, eccentric exercise protocol was developed (Edwards et al. 2007a).  During an eccentric 
muscle action, the exercising muscle applies continuous force as it lengthens, causing damage to 
the internal structure of the muscle fibres (Proske and Morgan, 2001).  This damage is greater 
than that observed with concentric (shortening) muscle contractions (Sorichter et al. 1999) and, in 
untrained individuals, leads to an inflammatory response in the muscle (Sorichter et al. 2006).  
For example, exercise elevates the levels of inflammatory mediators released from stressed cells 
within the damaged muscle tissue (Peake et al. 2005).  Numerous cytokines are also released, and 
may play a role in augmenting immune interactions (Peake et al. 2005).  Therefore, it possible 
that eccentric exercise, performed using the muscles located at the site of vaccine administration, 
improves the subsequent immune response by inducing a pro-inflammatory environment in the 
muscles.  In support of this theory, the extent of the self-reported pain and the change in upper 
arm limb circumference following eccentric exercise, both indirect indicators of muscle damage, 
were significantly positively correlated with the subsequent cell mediated immune response to 
the vaccination (Edwards 2007a).   
 
In light of these promising findings, it is important to improve the exercise intervention further to 
achieve the maximum adjuvant effect possible.  One factor that can be manipulated is the timing 
of the exercise relative to the vaccination.  Within the local muscle tissue, the complex 
inflammatory response to muscle damage evokes a number of changes, occurring almost 
immediately after the onset of muscle damage, and lasting up to 7 days post-exercise (Peake et al. 
2005).  Therefore, a number of different timepoints in the post-exercise recovery period may 
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provide the optimal environment for enhancing the immune response to vaccination.  As well as 
having clear implications for future clinical applications of such an intervention, a timing 
manipulation may also help elucidate the mechanisms underlying the exercise induced 
augmentation of vaccine responses.  
 
Previously, an augmented vaccine response was successfully induced using a protocol in which 
participants were vaccinated six hours post-exercise (Edwards et al 2007).  This timepoint was 
selected to coincide with the peak response of the cytokine interleukin-6 (IL-6) to eccentric 
exercise (MacIntyre et al. 2001).  High levels of IL-6 are associated with stronger antibody 
responses to live Francisella tularensis vaccination in humans (Krakauer 1995) and co-
administration of plasmids encoding IL-6 has been shown to enhance influenza vaccine efficacy 
in mice (Krakauer, 1995; Lee et al. 1999).  Further, the extent of the antibody response to the 
A/Panama strain was positively correlated with the IL-6 response to the acute stress tasks 
(Edwards et al 2006). Given these findings, the current study also included a group vaccinated six 
hours post-exercise to coincide with a predicted peak in IL-6.  
 
It is also important to include a group vaccinated at the point of peak muscle damage, as this is a 
key process that could underly the eccentric exercise-induced augmentation of antibody 
responses.  Peak muscle damage, defined by pain, swelling, loss of muscle function and the 
production of creatine kinase, is delayed after exercise cessation (Sorichter et al. 1999).  At 
approximately 48 hr post-exercise, there is a peak accumulation of inflammatory infiltrate 
comprised of cellular (e.g. neutrophils and mononuclear cells) (Fielding et al. 1993) and secreted 
(e.g. cytokines, heat shock proteins, uric acid) (Peake et al. 2005) factors.  We propose that this 
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heightened inflammatory environment may enhance antigenic recognition and clearance at the 
site of muscle damage. Therefore, in the current study, a second group were vaccinated 48 hr 
after exercise.   
 
Finally, a group were vaccinated immediately after exercise.  From a pragmatic perspective, this 
would simplify any future clinical application of this intervention.  There were also sound 
theoretical reasons to hypothesise that this might be effective.  It has been hypothesized that a 
redistribution of immune cells (Kruger et al. 2008), and subsequent demargination into sites of 
tissue damage immediately following stress, may be one of the principal mechanisms behind the 
acute-stress immunoenhancement hypothesis (Dhabhar et al. 1995).  Further, there is evidence 
that muscular contractions are associated with a short term increase in lymphatic drainage of the 
exercised muscle (Havas et al. 1997) which could subsequently enhance immune cell transport to 
and from the site of antigen administration (Swartz et al. 2008).  Therefore, a third exercise group 
were vaccinated immediately post-exercise in the current study.  
 
In summary, three exercise groups (immediate, 6 hr, 48 hr post-exercise) were compared with a 
non-exercising control group, in terms of their humoral and cell-mediated responses to influenza 
vaccination.   We hypothesised that the exercise groups would show augmented immune 
responses to the influenza vaccine in comparison to the control group, and that the timing of 
vaccination would influence the efficacy of the exercise intervention. 
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METHODS 
 
Participants 
 
One hundred and fifty-six healthy students (76 men, 80 women) at the University of Birmingham 
were recruited, and 155 completed the study (mean ± SD; age:  20.4 ± 2.4 years; body mass 
index:  22.8 ± 2.9 kg/m2).  None of the participants had received the influenza vaccine in the past 
year and none had reported influenza-like illness in the year prior to participation.  Exclusion 
criteria included smoking, a history of immune or cardiovascular disease, current acute infection 
or illness, pregnancy or suspected pregnancy, and a history of vaccine-related allergies or side 
effects.  Use of prescription medication within one month of participation was also an important 
exclusion criterion; but females taking the contraceptive pill were not excluded.  In addition, 
none of the participants reported having performed any resistance training in the 6 months prior 
to testing.  All participants were instructed to abstain from vigorous exercise and over-the-
counter medication for at least 24 hr, alcohol for at least 12 hr, and food or caffeine for at least 2 
hr prior to each session, and to refrain from over the-the-counter medication for up to 24 hr after 
the exercise / control task.  All participants provided written informed consent and the study 
protocol was approved by the Black Country Local Research Ethics Committee.  All participants 
were paid £30 or given research credits upon completion of the study.   
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Procedure 
 
Participants were pseudo-randomised, maintaining an even sex distribution, into one of four 
groups: immediate exercise group (n=38), 6 hr exercise group (n=39), 48 hr exercise group 
(n=39) or a resting control group (n=39).  Groups did not differ for stressful life events exposure, 
perceived stress and health behaviours (data not reported here); these factors have been 
associated with the extent of antibody responses (Burns et al. 2003; Cohen et al. 2001).  In the 
first session, baseline blood samples were taken, from an antecubital vein in the dominant arm, 
following a 20 min rest period.  Participants then had height and weight measured, and a test of 
maximum muscle strength was conducted.  In the second session, they completed either the 
eccentric exercise task (exercise groups) or remained quietly resting for 25 min (control group).  
Participants then returned to the laboratory at varying times, depending on group allocation, for 
session three; the resting control group received the vaccine immediately after task completion.   
During this session, a nurse administered the 2007/2008 northern hemisphere influenza vaccine 
(0.5 ml; Inactivated Split Virion BP, Sanofi Pasteur MSD, Batch no. B9676-1) via intra-muscular 
injection into the deltoid muscle of the non-dominant arm.  Participants returned to the laboratory 
at 28 days post-vaccination to provide blood samples for antibody and cell mediated immunity 
measurement.   
 
Exercise Task 
 
The exercise protocol has been described in detail elsewhere (Edwards et al. 2007a).  In brief, 
participants performed the eccentric portions of the bicep curl and lateral raise exercises, 
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contracting the biceps brachii and deltoid muscles of the non-dominant arm, respectively.  In both 
exercises, they were asked to lower the dumbbell in a controlled manner to a count of five.  The 
weights used were 85% of each participant’s concentric single repetition maximal (1RM) (1RM 
bicep curl:  11.68 ± 4.1 kg; 1RM lateral raise: 8.16 ± 2.9 kg); this intensity was chosen as it 
elicits muscle damage, whilst at the same time it is not too intensive, thus enabling all 
participants to complete the task.  All participants performed 50 repetitions of each movement.  
The task lasted approximately 25 min. 
 
Blood sampling   
 
Blood was collected in a 10 ml vacutainer containing potassium ethylene diaminetetraacetic acid 
(K3EDTA) (Becton-Dickinson, UK) at baseline and at the time of vaccination.  Tubes were 
stored on ice until centrifugation (3400 g for 10 min at 1 °C) and plasma was stored at −80 °C for 
later assessment of IL-6 and CK.  Blood serum was collected in a plain 10 ml vacutainer and 
allowed to clot for 1 hr at room temperature; and following centrifugation (3400 g for 5 min at 21 
°C), was stored at −20 °C for later antibody titre determination.  A 10ml lithium-heparin 
vacutainer was taken at 28 days post-vaccination for assessment of cell-mediated antigen specific 
immunity.   
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Assays  
 
Anti-influenza antibody titres were measured using a haemagglutination inhibition test analysed 
by the serology laboratory of GlaxoSmithKline Beecham at Dresden, Germany.  The trivalent 
2007/2008 Northern Hemisphere influenza vaccine contained three viral strains:   A/Solomon 
Islands/3/2006 (H1N1)-like strain; A/Wisconsin/67/2005 (H3N2)-like strain; and 
B/Malaysia/2506/2004-like strain.  The antibody results are reported as titres; a titre represents 
the reciprocal of the highest dilution having a positive response in the haemagglutination 
inhibition assay. 
 
Cell-mediated antigen-specific immunity was assessed by determining the levels of IFN-γ in cell 
culture supernatant following in vitro stimulation of blood with whole vaccine.  In brief, 1 ml of 
fresh lithium heparinised blood was incubated for 18 hr (5% CO2, 37 °C) with 100µL of 
complete vaccine.  This vaccine dose was found to be optimal based on a series of titrations 
carried out during pilot testing (unpublished data).  Supernatant was harvested by aspiration, 
centrifuged (200 g at 4 °C for 2 min) to remove cells, and frozen at −20 °C.  IFN-γ concentrations 
were measured in duplicate using a sandwich ELISA (catalogue number DY285; R&D Systems, 
UK).  All tests were performed according to the manufacturer’s recommendations.  A colour 
reaction (SIGMAFAST™ OPD, Sigma-Aldrich, UK) was stopped after 20 min (2N H2SO4, 
Fisher Scientific, UK) and read on a microplate reader (ELx800, BioTek©, USA) at 490 nm and 
650 nm, allowing adjustment for optical imperfections in the plate.  The recorded intra-assay and 
inter-assay variation for IFN-γ were 4.1 and 10.5 %, respectively.   
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Plasma IL-6 was measured using high-sensitivity ELISA (Quantikine HS Human IL-6 ELISA, 
R&D Systems, UK) according to manufacturer’s instructions.  The reported sensitivity of the 
assay was 0.039 pg/ml, with recorded intra-assay and inter-assay variation at 2.3 % and 9.6 %, 
respectively.  Plasma creatine kinase (CK) activity were measured using a semi-automated 
analyser (COBAS MIRA S-plus, ABX, UK) and diagnostic reagents (ABX diagnostics, UK).  
CK samples were analysed in triplicate, and coefficient of variations for CK were calculated as 
1.9%. 
 
Limb circumference, pain and perceived exertion 
 
Muscle soreness was assessed using a visual analogue scale (Melzack, 1987) with anchors of 0 
(no pain) and 100 (worst possible pain), to indicate an overall pain rating regarding the non-
dominant arm.  These measures were completed by all participants immediately after the task, 
and again immediately prior to vaccination.  Change in upper arm circumference was used to 
quantify the amount of swelling in the non-dominant arm pre-task, immediately post-task and 
again at 6 hr post-task.  Measurements were taken in an unblinded manner using tape measure at 
the point of flexed maximal circumference of the upper arm, and, for the forearm, 5 cm below the 
elbow crease in the inside of the arm.  After locating the site of measurement, participants let 
their arm hang, relaxed, by their side for all measurements.  Measurement sites were marked with 
a pen in two places around the arm at the first testing session to ensure consistent placement of 
tape measure.  Exercise group participants also provided a rating of perceived exertion (Borg, 
1970) immediately after the task using a 15-point scale (6= “no exertion at all”, 20= “maximal 
exertion”), immediately after the task. 
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Statistical analysis 
 
Due to the skewed distributions of the antibody titres and IFN-γ concentrations, analyses were 
performed on log10 transformed values.  All analyses were conducted using repeated measures 
(antibody titres; IL-6; CK) or univariate (cell mediated immunity pain; percentage change in limb 
circumference) analysis of variance.  We made an a priori decision to follow a traditional drugs 
trial analytic strategy.  As such, it was firstly investigated whether there was any difference 
between treatment and control i.e. all exercise groups combined were compared with the control 
group.  Secondly, the treatment groups were compared i.e. compared within the three exercise 
groups only.  Finally, a series of ANOVAs compared each individual exercise group with each 
other and with the control group.  As previous studies have found sex differences in intervention 
efficacy (Edwards et al. 2006; Edwards et al. 2007a), sex was entered as a between-subject factor 
in all parameter analyses.  If no sex effects were found at this stage for a particular parameter, it 
was excluded from further analyses of that parameter.  Effect sizes are represented by η2, and 
differences in degrees of freedom reflect occasional missing data.  
 
Results 
 
Antibody titres 
 
Table I displays the overall geometric mean influenza antibody titres for A/Solomon Islands, 
A/Wisconsin and B/Malaysia at baseline and 28 days post-vaccination.  A 2 Sex (male, female) × 
3 Strain (A/Solomon Islands, A/Wisconsin, B/Malaysia) × 2 Time (0, 28 days) ANOVA on log 
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transformed antibody titres revealed significant Strain (F(2,151)=22.96, p<.001, η2=.23), Time 
(F(1,152)=1164.91, p<.001, η2=.89), and Strain × Time effects (F(2,151)=12.41, p<.001, η2=.14).  
As anticipated, separate ANOVAs (2 Time) confirmed that antibodies titres to all viral strains 
increased from baseline to 28 days post-vaccination (F(1,153)=340.37–728.52, ps <.001, η2=.69–
.83).  Fold changes were calculated by dividing the geometric mean antibody titre at 28 days by 
the relevant baseline titre; results exhibited by each strain are displayed in Table I. 
 
In order to compare differences between experimental groups, a two step analytical procedure 
was adopted.  Firstly, the control group was compared with all exercise groups to establish if 
there was an overall adjuvant effect of exercise, then comparisons within exercise groups were 
conducted, followed by individual pairs of ANOVAs comparing individual exercise groups with 
each other and with control. 
 
Exercise v control comparison 
 
A 2 Group (combined exercise groups, control) × 2 Sex × 2 Time ANOVA revealed that there 
were no Group × Time interactions for antibody responses to A/Solomon Islands (F(1,150)=0.32, 
p=.57, η2<.01), A/Wisconsin (F(1,150)=2.91, p=.13, η2=.02), or B/Malaysia (F(1,151)=2.18, 
p=.14, η2=.01) viral strains.  Further, no main effects of Sex, and no Sex × Time interactions, 
were identified in the response to any of these strains.   
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Exercise groups comparison 
 
A 3 Group (immediate, 6 hr, 48 hr) × 2 Sex × 2 Time ANOVA again revealed no significant 
Group × Time interactions for antibody responses to A/Solomon Islands (F(2,110)=0.19, p=.83, 
η
2<.01), A/Wisconsin (F(2,110)=1.67, p=.19, η2=.03), or B/Malaysia (F(2,110)=2.34, p=.10, 
η
2
=.04) viral strains.  Finally, ANOVAs were conducted to establish whether any of the exercise 
groups differed from each other, or from control; these analyses revealed no significant 
differences between any of the four groups (all p>.05; see Figure I).   
 
Table I.  Geometric mean (95% confidence intervals) antibody titres and fold change scores for 
the three viral strains of influenza at baseline and 28 days post-vaccination.   
 
Viral strain Baseline 28 days post-vaccination Fold change 
A/Solomon Islands 33 (27 − 40) 761 (652 − 888)a 23.06 
A/Wisconsin 36 (30 − 44) 346 (294 − 408)a 9.61 
B/Malaysia 23 (20 − 27) 317 (262 − 383)a 13.78 
 
a
 Significantly different from pre-vaccination (p <.05) 
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Figure I.  Mean (SE) log-transformed antibody titres in each experimental group, against the 
three viral strains of influenza at baseline and 28 days post-vaccination. 
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Figure III.  Log 10 IFN-gamma at 28 days in the exercise groups (combined)
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γ response to whole 
, p=.99, η2<.01) 
p=.45, η2=.02).  
p>.05).   
 
and control group.  
 57 
Limb circumference and arm pain 
 
A 4 Group (immediate, 6 hr, 48 hr, control) ANOVA comparing limb circumference percentage 
changes from baseline to post-task, between all experimental groups, revealed significant Group 
effects for upper (F(3,135)=4.34, p=.01, η2=.09) and forearm circumference (F(3,136)=3.86, 
p=.01, η2=.08) (see Table II).  Tukey post-hoc analyses revealed that each exercise group had a 
significantly greater percentage increase in both upper arm and forearm circumferences compared 
with control (ps<.01).  None of the exercise groups differed from each other. 
 
Similarly, a 4 Group (immediate, 6 hr, 48 hr, control) ANOVA comparing self-reported arm pain 
scores between all experimental groups revealed no significant Group effects immediately post-
task (F(2,109)=2.45, p=.09, η2=.04), but significant Group effects were observed immediately 
prior to vaccination (F(3,145)=10.71, p<.01, η2=.18) (see Table II).  Tukey post-hoc comparisons 
revealed that, at the time of vaccination, both the immediate (p<.01) and 48 hr groups (p=.01), 
but not the 6 hr group (p=.26), reported higher pain than the control group.  Further, the pain 
rating of the immediate group was also significantly higher than the 6 hr group (p<.01); there 
were no other group differences. 
 
IL-6 and CK responses to exercise 
 
Figure II illustrates plasma IL-6 concentrations at baseline and at the time of vaccination for each 
of the four experimental groups.  A 2 Group (combined exercise groups, control) × 2 Sex (male, 
female) × 2 Time (baseline, time of vaccination) ANOVA comparing the control group with the 
 58 
combined exercise groups revealed a close to significant Group × Time effect (F(1,133)=3.49, 
p=.06; η2=.03); suggesting that exercise groups had elevated concentrations of IL-6 at the time of 
vaccination, compared with the control group.  Further, no main effects of Sex and no Sex × 
Time interactions were identified (p >.05).  A 3 Group (immediate, 6 hr, 48 hr) × 2 Time 
(baseline, time of vaccination) ANOVA comparison of the three separate exercise groups 
revealed no significant Group × Time interaction (F(2,99)=0.69, p=.51; η2=.01).  However, 
comparing the control group with each of the exercise groups in turn, IL-6 appeared to be 
elevated in both the immediate (F(1,59)=3.44, p=.07; η2=.07) and 48 hr  (F(1,66)=3.77, p=.06; 
η
2
=.05) exercise groups compared with the control group, but these results were non-significant.  
Unexpectedly, there was no significant difference between the IL-6 levels in the 6 hr and the 
control group (F(1,64)=2.05, p=.16; η2=.03).   
 
Figure II illustrates plasma CK activity s at baseline and at the time of vaccination in each of the 
four groups.  A 2 Group × 2 Sex × 2 Time ANOVA revealed a significant main effect of Time 
(F(1,118)=6.32, p=.01; η2=.05), whereby CK increased from baseline to time of vaccination.  
However, no Group × Time, Sex × Time, or Group × Sex × Time interactions were observed.  A 
comparison of the three separate exercise groups using a 3 Group (immediate, 6 hr, 48 hr) × 2 
Time ANOVA revealed no significant Time x Group interaction (F(2,82)=1.4, p=.08; η2=.03).  2 
Group × 2 Time ANOVAs comparing the control group with each of the exercise groups in turn 
revealed that the 48 hr group had, as expected, elevated CK levels compared with control 
(F(1,58)=4.34, p=.04; η2=.07).  No further group differences were found (all p>.05).  
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Table II.  Percentage change (mean ± SD) in upper arm and forearm limb circumference from baseline to immediately post-task, 
and upper arm pain immediately post-task, and immediately prior to vaccination.   
 
 
a
 significantly different from control group (p≤.01) 
b
 significantly different from immediate exercise group (p<.01) 
 
 
 
 Control 
Immediate 
exercise 
6 hour 
exercise 
48 hour 
exercise 
Group Effects 
Change in upper arm limb 
circumference (%) 
0.01 ± 0.1 1.45 ± 0.36a 0.86 ± 0.32a 1.21 ± 0.27a F(3,135)=4.34, p<.01, η2=.09 
Change in forearm limb 
circumference (%) 
0.08 ± 0.1 1.57 ± 0.26a 2.17 ± 0.28a 1.57 ± 0.36a F(3,136)=3.86, p=.01, η2=.08 
Arm pain immediately post-task 
(1-100) 
n/a 32.1 ± 4.6 29.1 ± 3.6 20.7 ± 2.8 F(2,109)=2.45, p=.09, η2=.04 
Arm pain at time of vaccination 
(1-100) 
1.1 ± 0.1 22.1 ± 3.6a 8.1 ± 2.6b 13.0 ± 3.0a F(3,145)=10.71, p<.01, η2=.18 
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Figure II.  Plasma CK (top; U/l) activity and (IL-6; pg/ml) concentrations in each experimental 
group at baseline and at the time of vaccination. 
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DISCUSSION  
 
The current study investigated the effects of an acute bout of eccentric arm exercise on the 
immune response to vaccination in healthy young adults, and whether the efficacy of this 
intervention was modulated by the timing of the exercise relative to vaccination.  All three viral 
strains contained in the 2007/2008 influenza vaccine elicited strong antibody responses (see 
Table I), and eccentric exercise did not further augment these responses, compared with the 
control group.  There was also no difference in cell-mediated immunity between the groups.  
Although these null findings were unexpected, they are consistent with previous research, in 
which exercise-induced augmentation was only observed when the control group had relatively 
poor responses (Edwards et al. 2006; Edwards et al. 2007a; Edwards et al. 2008). 
 
In a previous eccentric exercise study, antibody responses to both the A/Wyoming and B/Jiangsu 
strains were enhanced in female participants who completed an acute exercise task; both strains 
were characterised by poorer antibody responses in the control group (Edwards et al. 2007a).  In 
contrast, the A/New Caledonia strain, which had larger antibody responses in the control group, 
was not further improved by exercise.  A similar pattern occurred with the measure of cell 
mediated immunity; men in the control group had poorer IFN-γ production than women, and it 
was men that demonstrated an exercise-induced augmentation in this measure.  Similar effects 
were demonstrated in another study; the relatively poor antibody responses to the A/Panama 
influenza strain shown by women in the control group were enhanced in those who undertook an 
exercise or psychological stress intervention (Edwards 2006). Again, the other two strains 
displayed greater immunogenicity and no effect of exercise was observed.  Participants in this 
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study also received the meningitis A+C vaccination.  Here, weak antibody responses to 
meningococcal A were shown by men in the control group; again, these were enhanced in both 
exercise and stress groups.  Taken together, the data presented in this study and the findings from 
previous studies suggest that exercise may be an effective adjuvant where there are typically 
relatively poor immune responses.  This may explain why an enhancement was not observed in 
the current study, in which the vaccine induced high levels of immunity even in the control 
groups. 
 
A second aim of this study was to investigate whether the timing of vaccine administration 
following eccentric exercise affected the immune response to vaccination.  Three specific time-
points were chosen that coincide with particular physiological and immunological processes that 
follow eccentric exercise.  As anticipated, a number of physiological differences were observed 
between the three exercise groups at the time of vaccination, as a result of the different timings of 
exercise.  For example, the immediate exercise group exhibited elevated pain (Proske and 
Morgan, 2001) and the 48 hour group reported both elevated pain, indicative of the characteristic 
delayed onset muscle soreness associated with eccentric exercise, and elevated plasma CK levels 
(Rodenburg et al. 1993).  Despite these distinct physiological group profiles, exercise timing was 
not associated with the immune response to vaccination.  These findings were unexpected but not 
surprising given that no overall effect of exercise was found.  Future research should investigate 
the effects of exercise timing on the immune response to vaccines that elicit poorer vaccine 
responses.   
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Contrary to expectations, IL-6 was not highest in the 6 hr exercise group; this cytokine was in 
fact more elevated in the other exercise groups.  This observation suggests that the inflammatory 
response to acute eccentric exercise did not follow the same kinetics as has been previously 
reported (MacIntyre et al. 2001; Paulsen et al. 2005); this is not without precedent (Suzuki et al. 
2002; Sorichter et al. 2006), and suggests that IL-6 kinetics post-exercise may be complex.  
Further, in contrast to our previous work, IL-6 did not predict antibody response.  This may be 
due to the unexpected IL-6 kinetics described.  Alternatively, there is evidence to suggest that 
plasma levels of IL-6 may not be an accurate representation of intramuscular IL-6 activity 
(Jonsdottir et al. 2000); it remains possible that the extent of the intramuscular IL-6 response may 
predict antibody response.  Finally, given that all groups showed elevated IL-6 relative to control, 
it is unlikely that this is the source of the null findings reported in this study. 
 
This study was the largest of its type to date and has a robust design to investigate the research 
question.  However, in light of the null findings reported, it is important to consider possible 
methodological limitations.  A key consideration is the choice of participants.  The participants 
used in this study were healthy young adults with no known immune dysfunction; this population 
was chosen as we believe it is important to optimise the efficacy of this intervention in healthy 
individuals before application to more vulnerable populations.  However, this choice, and the 
subsequent strong immune responses shown by the healthy participants, may have been 
responsible for the null findings.  It is clear that future research would be well-directed towards 
investigating the impact of this intervention in populations with known immune dysfunction, 
such as the elderly.     
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In summary, there were no differences in vaccine response between the four exercise groups, 
despite the distinct physiological profiles observed in each of the exercise groups.  We 
hypothesise that this result was due to the relatively robust immune responses seen to the 
influenza vaccine.  These findings are consistent with the notion that acute exercise may only be 
an effective adjuvant to vaccination where the control responses are relatively poor (Edwards et 
al. (2007b).  To explore this possibility further, future research should investigate less 
immunogenic vaccines, or immuno-compromised individuals, such as chronically stressed 
individuals (Burns et al. 2003), the elderly (Goodwin et al. 2006) or HIV patients (Kroon et al. 
1994).  
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CHAPTER THREE 
 
ECCENTRIC EXERCISE AS A  
BEHAVIOURAL ADJUVANT  
TO VACCINATION:   
ISSUE OF EXERCISE INTENSITY 
 
ABSTRACT 
 
Acute exercise prior to vaccination can improve the antibody response to influenza vaccination.  
However, both the optimal exercise protocol and the mechanisms underpinning this adjuvant 
effect remain unclear.  The aim of the current study was to determine whether exercise intensity 
influenced the efficacy of the intervention.  One hundred and sixty healthy young adults were 
randomly assigned to a resting control group or one of three intervention groups, who exercised 
at an intensity of 60%, 85%, or 110% of their pre-determined concentric one-repetition maximal.  
The exercise groups performed 50 repetitions of the eccentric portion of both bicep curl and 
lateral raise movements.  All participants then immediately received a reduced-dose (50 % 
recommended dose) influenza vaccine.  Antibody titres to the three viral strains contained in the 
vaccine were measured at baseline and at 28 days post-vaccination.  Compared with the control 
group, exercise enhanced the antibody response to the least immunogenic of the three strains 
(B/Florida).  In addition, the exercise groups showed an augmented response to the A/Uruguay 
strain compared with control; however, this effect was observed only in men.  The intervention 
had no effect on the antibody responses to the most immunogenic strain, A/Brisbane.  Finally, 
antibody responses were unrelated to the intensity of the exercise bout.  In conclusion, our 
 70 
findings provide further evidence of exercise as an adjuvant to enhance vaccination responses. 
The results further show that responses to the low-immunogenic antigens are particularly 
responsive to augmentation by acute eccentric exercise. 
 
INTRODUCTION 
 
Vaccination against infectious diseases is one of the most successful public health interventions 
of all time (Nicholson et al. 2003).  However, there is considerable inter-individual variation in 
the efficacy of vaccination, and additional strategies to improve immune responses are needed.  
Recently, behavioural interventions, such as acute exercise administered prior to vaccination, 
have been shown to enhance the immune response in both animals (Dhabhar, 2002) and humans 
(Edwards et al. 2006; 2007; 2008).  For example, exposure to an acute bout of cycling exercise 
improved the antibody response to influenza vaccination in women (Edwards et al. 2006) and to 
meningococcal A vaccination in men (Edwards et al. 2007). 
 
A recent study showed an adjuvant effect to influenza vaccination using a resistance-based, 
eccentric exercise protocol (Edwards et al. 2007).  During an eccentric muscle action, the 
exercising muscle applies continuous force as it lengthens, causing damage to the internal 
structure of the muscle fibres (Proske and Morgan, 2001).  This damage is greater than that 
observed with concentric (shortening) muscle actions, as indicated by a substantial increase in 
plasma creatine kinase (Sorichter et al. 1999).  When conducted in untrained participants, 
eccentric exercise reliably causes muscle damage and leads to a localised inflammatory response 
in the muscle (Sorichter et al. 2006).  It is hypothesised that the influx of immune cells and the 
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release of inflammatory mediators associated with this muscle damage creates a pro-
inflammatory environment that may augment the immune response to vaccination by, for 
example, the release of ‘danger signals’ or by activating dendritic cells (Gallucci et al. 1999; 
Rock et al. 2005).  Given that eccentric exercise of the arm allows the localisation of this muscle 
damage to the specific site of vaccine administration, it is hypothesised this heightened 
inflammatory environment may be a particularly effective behavioural adjuvant.  A recent study 
showed that the antibody response to influenza vaccine was enhanced in women following an 
acute eccentric exercise bout (Edwards et al. 2007).  Although these encouraging findings 
demonstrate an adjuvant effect of eccentric exercise, further investigation is needed to maximise 
the efficacy of this intervention.  
 
Given that the degree of muscle damage is related to exercise intensity, it is possible that the 
efficacy of the adjuvant effect could be adjusted by manipulating the exercise intensity.  For 
clinical applicability, it is important to determine the minimum intensity at which exercise causes 
significant improvements to vaccine responses.  Further, intensity modulation may help elucidate 
the mechanisms underpinning the adjuvant effect of exercise.  For example, an intensity-
dependent augmentation may suggest that muscle damage severity, and the concomitant 
inflammation, are key to the immuno-enhancement effects.  On the other hand, if there is no 
effect of intensity this will have important clinical application i.e. a more modest exercise bout 
can be utilised.  This study therefore compared the efficacy of a relatively low (60% of concentric 
one repetition maximum (1RM)), medium (85% 1RM), and high (110% 1RM) intensity eccentric 
exercise intervention.  
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A key finding from the previous exercise and vaccination studies conducted by our group is that 
stress-induced immunoenhancement manifests only when antigens in the vaccine induce a poor 
immune response in the host.  For example, when there are clear sex differences in the antibody 
response to a particular strain of the vaccine, the exercise-induced enhancements of this response 
are always confined to the sex who had mounted the poorer control response (Edwards et al. 
2008; 2007a; 2006).  For example, it has been shown before that control women showed a 
relatively poor response to the A/Panama strain of the influenza vaccine, compared with men; 
acute cycling exercise improved the antibody response to this strain in women, but not men 
(Edwards et al. 2006).  The other strains, which induced generally robust responses and 
demonstrated no sex differences in their immunogenicity, showed no added benefit from the 
exercise intervention.  Similarly, the antibody response to meningococcal A was enhanced by 
cycling exercise in men, who showed weaker responses than women in the control group 
(Edwards et al. 2008).  It would thus appear that exercise augments poor responses, but does not 
enhance robust responses.  Further support of this hypothesis emerged from a recent study, which 
demonstrated that the antibody responses to influenza vaccination were not enhanced by 
eccentric exercise when the vaccine contained viral strains that induced robust immunogenic 
responses (Chapter Two).  In light of these findings, a reduced dose (50% recommended dose) 
vaccine was administered in this study in order to further investigate whether poorer responses, 
induced by a less immunogenic vaccine, are enhanced by exercise. 
 
The aim of the study was to investigate whether exercise augmented the immune response to a 
reduced dose vaccine, and whether the intensity of exercise influenced the efficacy of the 
intervention.  We hypothesised that the exercise groups would show augmented immune 
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responses to the influenza vaccine in comparison to the control group, and that higher intensity 
exercise would be associated with greater immune enhancement.  
 
METHODS 
 
Participants 
 
One hundred and sixty healthy young students (80 men) were recruited from the University of 
Birmingham, of which one hundred and fifty-eight (79 men) completed the study (mean ± SD 
age:  21.01 ± 2.5 years; body mass index:  22.75 ± 2.8 kg/m2).  The majority of participants (N = 
115) had not previously received the influenza vaccine used in the present study, and none 
reported influenza like-illness in the year prior to participation.  Forty-five participants had 
received an influenza vaccine in the previous five years.  As all three strains within the northern 
hemisphere winter 2008/2009 influenza vaccine differed from that of previous years, these 
participants were deemed eligible for participation.  Importantly, further analysis revealed no 
significant differences between these groups in terms of their antibody responses to any of the 
three strains (data not presented).  Exclusion criteria included smoking, a history of immune or 
cardiovascular disease, current acute infection or illness, pregnancy or suspected pregnancy, and 
a history of vaccine-related allergies or side effects.  Use of prescription medication within one 
month of participation was also an important exclusion criterion; but females taking the 
contraceptive pill were not excluded.  In addition, none of the participants reported having 
performed any resistance training in the 6 months prior to testing.  All participants were 
instructed to abstain from vigorous exercise and over-the-counter medication for at least 24 h, 
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alcohol for at least 12 h, and food or caffeine for at least 2 hr prior to each session, and to refrain 
from over the-the-counter medication for up to 24 hr after the exercise / control task.  All 
participants provided written informed consent and the study protocol was approved by the Black 
Country Local Research Ethics Committee.  All participants were paid £30 or given research 
credits upon completion of the study. 
 
Procedure 
 
Participants were pseudo-randomised, maintaining an even sex distribution, into either one of 
three exercise groups, exercising at 60%, 85% or 110% of their concentric one repetition 
maximal (1RM) or a resting control group (all groups N = 40).  Groups did not differ on stressful 
life events exposure, perceived stress, and health behaviours (data not reported here); these 
factors have been associated with augmentation of antibody responses (Burns et al. 2003; Cohen 
et al. 2001).  In the first session, baseline blood samples were taken from an antecubital vein in 
the dominant arm, following a 20 min rest period.  Participants then had height and weight 
measured, and a test of maximal muscle strength was conducted.  Next, they completed the 
eccentric exercise task, with their non-dominant arm, at the relevant exercise intensity (exercise 
groups) or remained quietly resting for 25 min (control group).  Immediately after task 
completion, a nurse administered a reduced dose (0.25 ml; 50% adult recommended dose) 
2008/2009 northern hemisphere influenza vaccine (Fluarix, GlaxoSmithKline, Inactivated Split 
Virion, Lot no. AFLUA384AB) via intra-muscular injection into the deltoid muscle of the non-
dominant arm.  Participants returned to the laboratory after one day to provide a blood sample for 
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muscle damage and inflammatory marker measurement, and at 28 days post-vaccination to 
provide a blood sample for antibody determination.   
 
Exercise Task 
 
The exercise protocol has been adapted from elsewhere (Edwards et al. 2007).  In brief, following 
the determination of maximal muscle strength (1 Repetition Maxima:  Bicep Curl:  12.35 ± 2.38 
kg; Lateral Raise:  8.92 ± 1.59 kg), participants performed the eccentric portions of the bicep curl 
and lateral raise exercises, contracting the biceps brachialis and deltoid muscles of the non-
dominant arm, respectively.  In both exercises, they were asked to lower the dumbbell in a 
controlled manner.  All participants performed 50 repetitions of each muscle action (10 sets of 5 
repetitions).  They completed a set of lateral raises, rested 15 s, completed a set of bicep curls, 
and rested 30 s before the next set of lateral raises.  The task lasted approximately 25 min. 
 
Blood sampling   
 
Blood was collected in a 10 ml vacutainer containing potassium ethylene diaminetetraacetic acid 
(K3EDTA) (Becton-Dickinson, UK) at baseline and 24 hr post- exercise.  Tubes were stored on 
ice until centrifugation (3400 g for 10 min at 1 °C) and plasma was stored at −80 °C for later 
assessment of interleukin-6 and creatine kinase.  Blood serum was collected in a plain 10 ml 
vacutainer and allowed to clot for 1 hr at room temperature; and following centrifugation (3400 g 
for 5 min at 21 °C), was stored at −20 °C for later antibody titre determination. 
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Assays  
 
Anti-influenza antibody titres were measured using a haemagglutination inhibition test analysed 
by the serology laboratory of GlaxoSmithKline Beecham at Dresden, Germany.  The influenza 
vaccine contained three viral strains:  A/Brisbane/59/2007 (H1N1)-like strain:  
A/Brisbane/59/2007; A/Brisbane/10/2007 (H3N2)-like strain:  A/Uruguay/716/2007; 
B/Florida/4/2006-like strain:  B/Florida/4/2006.  The antibody results are reported as titres; a titre 
represents the reciprocal of the highest dilution having a positive response in the 
haemagglutination inhibition assay. 
 
Plasma IL-6 was measured using high-sensitivity ELISA (Quantikine HS Human IL-6 ELISA, 
R&D Systems, UK) according to the manufacturer’s instructions.  The reported sensitivity of the 
assay was 0.039 pg/mL, with recorded intra-assay and inter-assay variation 3.9%, and 8.4%, 
respectively.  Plasma creatine kinase (CK) activity s were measured using a semi-automated 
analyser (COBAS MIRA S-plus, ABX, UK) and diagnostic reagents (ABX diagnostics, UK).  
CK samples were analysed in triplicate, and coefficient of variations for CK were calculated as 
1.18%. 
 
Limb circumference, pain and perceived exertion 
 
Muscle soreness was assessed using a visual analogue scale with anchors of 0 (no pain) and 100 
(worst possible pain) to indicate pain in the exercised arm (Melzack, 1987).  Participants rated 
their pain twice immediately after task completion; one rating was giving with reference to the 
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arm resting by their side and the other while they replicated the movements of the exercise task 
without the weights.  Change in upper and forearm limb circumferences were used to gauge the 
amount of swelling in the exercised arm.  Measurements were taken in an unblinded manner 
using tape measure at the point of flexed maximal circumference of the biceps (upper arm) and 5 
cm below the elbow crease in the inside of the arm (forearm), with the arm relaxed by the 
participants’ side.  Arm circumference was recorded at pre-task, immediately post-task, and at 24 
hr post-task; measurement sites were marked with pen in two places to ensure consistent 
placement of tape measure.  Participants also provided a rating of perceived exertion , using 
Borg’s (1970) 15-point scale (6= “no exertion at all”, 20= “maximal exertion”), immediately 
after the exercise task. 
 
Statistical analysis 
 
Due to the skewed distributions of the antibody titres analyses were performed on log10 
transformed values.  All analyses were conducted using repeated measures (antibody titres; IL-6; 
CK) or univariate (cell mediated immunity pain; percentage change in limb circumference) 
analysis of variance.  In each case, the following analytical strategy was adopted.  For example, it 
was first investigated whether there was any difference between treatment and control i.e. all 
exercise groups combined were compared with the control group.  Secondly, the three treatment 
groups were compared with each other.  Finally, a series of ANOVAs compared individual 
exercise groups with each other and with the control group.  As previous studies have found sex 
differences in intervention efficacy (Edwards et al. 2006; Edwards et al. 2007), sex was entered 
as a between-subject factor in all parameter analyses.  If no sex effects were found at this stage 
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for a particular parameter, it was excluded from further analyses of that parameter.  Univariate 
post-hoc analyses were conducted using Tukey.  Effect sizes are represented by η2, and 
differences in degrees of freedom reflect occasional missing data.  Pearson correlations were used 
to examine the associations between antibody titre change scores with responses to the exercise 
task (change in CK, IL-6, pain ratings, limb circumference).  These latter analyses were 
performed only within the exercise group.   
 
RESULTS 
 
Antibody titres 
 
Table I displays the overall geometric mean antibody titres specific to each viral strain of 
influenza, at baseline and 28 days post-vaccination, for the overall cohort and each individual 
group.  A 2 Sex (male, female) × 3 Strain (A/Brisbane, A/Uruguay, B/Florida) × 2 Time 
(baseline, 28 days) ANOVA on log transformed antibody titres revealed significant Strain 
(F(2,149)=4.82, p<.01, η2=.87), Time (F(1,150)=8.92, p<.01, η2=.86), and Strain × Time 
(F(2,149)=60.04, p<.01, η2=.45) effects.  As anticipated, separate ANOVAs (2 Time) confirmed 
that antibodies titres to all viral strains increased from baseline to 28 days:  A/Brisbane 
(F(1,151)=716.64, p<.01, η2=.83); A/Uruguay (F(1,155)=299.73, p<.01, η2=.66); B/Florida 
(F(1,157)=283.3, p<.01, η2=.64).  A series of ANOVAs (2 Strain × 2 Time) comparing each 
strain response revealed that the vaccine induced different response levels for each strain 
(F(1,150)>72.59, p<.01, η2>.33).  The largest fold increase was exhibited by A/Brisbane (19.25), 
whereas A/Uruguay (6.25) displayed greater increases than B/Florida (4.68) which displayed the 
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smallest change; fold increases were calculated by dividing the geometric mean antibody titre at 
28 days by the baseline titre.   
 
Effects of exercise on antibody responses 
 
The first analytic step was to compare the control group to the combined exercise group, in order 
to establish if there was an adjuvant effect of exercise.  A series of 2 Group (combined exercise 
groups, control) × 2 Sex (male, female) × 2 Time (0, 28 days) ANOVAs revealed a significant 
Group × Time interaction for B/Florida (F(1,154)=7.17, p=.01, η2=.04).  There were no Group × 
Time interactions for A/Brisbane (F(1,148)<0.01, p=.98, η2<.01) and no Sex × Time, or Group × 
Sex × Time interactions were observed for either A/Brisbane or B/Florida strains.  Similarly, 
there was no Group × Time interaction for A/Uruguay (F(1,152)=0.14, p=.71, η2<.01), however 
there was however a significant Sex × Time interaction (F(1,152)=3.94, p=.049, η2=.03); 
demonstrating that women had better antibody responses to this strain than men (see Figure I).  
There was also a significant Group × Sex × Time interaction for A/Uruguay (F(1,152)=5.70, 
p=.02, η2=.04).  This effect was further investigated by performing a 2 Group × 2 Time ANOVA 
for men and women separately.  Men showed a significant Group × Time interaction for 
A/Uruguay (F(1,76)=4.51, p=.04, η2=.06), whereby exercise men had higher responses than men 
in the control group.  No Group × Time effects were found in women for this strain 
(F(1,76)=1.75, p=.19, η2=.02). 
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Table I.  Geometric mean (95% confidence intervals) antibody titres against the three viral strains of influenza at baseline and 28 
days post-vaccination for all participants combined, and for each group.   
 
 A/Brisbane A/Uruguay B/Florida 
Baseline 28 days Baseline 28 days Baseline 28 days 
Overall 20 (17 − 23) 385 (320 − 463)a 16 (14 − 18) 100 (79− 126)a 246 (206 − 294) 1152 (1028 − 1290)a 
Control 16 (13 − 19) 333 (232 − 476)a 17 (13 − 23) 104 (64 − 169)a 388 (300 − 501) 1220 (1046 − 1423)a 
60 % 22 (16 − 32) 425 (287 − 632)a 17 (14 − 21) 116 (76 − 177)a 197 (128 − 303) 1433 (1127 − 1821)a 
85 % 19 (14 − 27) 323 (221 − 473)a 15 (12 − 18) 129 (79 − 212)a 180 (122 − 264) 813 (627 − 1056)a 
110 % 15 (12 − 19) 440 (286 − 675)a 14 (11 − 17) 61 (38 − 99)a 270 (200 − 370) 1220 (951 − 1565)a 
 
a
 Significantly different from baseline (p <.05) 
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Figure I.  Mean (SE) log-transformed antibody titres in men and women in both the exercise 
groups (combined) and control group.  Titres are displayed for each of the three viral strains of 
influenza at baseline and 28 days post-vaccination.   
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Effects of exercise intensity on antibody responses 
 
The next stage of the analysis compared the three exercise groups in terms of their efficacy in 
augmenting the antibody response to the influenza vaccination. A series of 3 Group (60%, 85%, 
110%) × 2 Time (baseline, 28 days) ANOVAs on individual strains revealed a close to significant 
Group × Time effect for A/Uruguay (F(2,111)=2.93, p=.058, η2=.05).  Subsequently, a series of 
ANOVAs comparing each of the exercise groups revealed that the 85% group had greater 
elevations in antibody titre than the 110% group (F(3,150)=3.92, p=.01, η2=.07); there were no 
other significant differences between the three groups (all ps < .16).     
 
Limb circumference and arm pain 
 
A 2 Group (combined exercise groups, control) ANOVA comparing limb circumference 
percentage changes from baseline to post-task revealed significant Group effects for upper 
(F(1,152)=30.78, p<.01, η2=.17) and forearm (F(1,151)=10.96, p<.01, η2=.07) circumference.  
These results indicated that all exercise groups had significantly greater percentage increases in 
upper and forearm limb circumference in comparison to control.  A series of 3 Group (60%, 85%, 
110%) ANOVAs revealed a Group effect for the upper (F(2,115)=3.13, p=.05, η2=.05) and 
forearm (F(2,113)=4.58, p=.012, η2=.08) circumference; Tukey post-hoc analyses confirmed a 
dose-dependent response with the higher intensity group exhibiting greater changes than the other 
groups (see Table II). 
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Similarly, a 2 Group (combined exercise groups, control) ANOVA comparing self-reported arm 
pain scores revealed significant Group effects for resting (F(1,152)=12.02, p<.01, η2=.07) and 
movement (F(1,152)=35.26, p<.01, η2=.19) arm pain immediately post-task.  A series of 3 Group 
(60%, 85%, 110%) ANOVAs revealed a Group effect for movement (F(2,116)=4.14, p=.02, 
η
2
=.07) but not resting (F(2,116)=1.21, p=.30, η2=.02) arm pain.  Tukey post-hoc analyses 
confirmed a dose-dependent response for movement arm pain with the 85% and 110% groups 
exhibiting greater changes than the 60% group (see Table II). 
 
CK and IL-6 responses to exercise 
 
Figure II illustrates plasma CK activity s at baseline and at 24 hr post-exercise in each of the four 
groups.  A 2 Group (combined exercise groups, control) × 2 Sex (male, female) × 2 Time 
(baseline, 24 hr) ANOVA revealed a Group × Time effect (F(1,140)=4.89, p=.03; η2=.03); 
exercise groups had elevated concentrations of IL-6 at the time of vaccination, compared with the 
control group.  A 3 Group (60%, 85%, 110%,) × 2 Time (baseline, 24 hr post-exercise) ANOVA, 
comparing changes within the three exercise groups, revealed a significant Group × Time 
interaction (F(2,100)=7.66, p<.01; η2=.13).  A series of ANOVAs comparing the changes 
between the separate exercise groups showed that the 110% exercise group had a greater increase 
than the 60% (p<.01) and 85% groups (p<.01); there was no significant difference between the 
60% and 85% groups (p=.07).  No main effects of Sex and no Sex × Time interactions were 
identified for CK in any of the above analyses (p >.05). 
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Figure II illustrates plasma IL-6 concentrations at baseline and 24 hr post-exercise.  A 2 Group 
(combined exercise groups, control) × 2 Sex (male, female) × 2 Time (baseline, 24 hr post-
exercise) ANOVA revealed a significant main effect of Time (F(1,141)=14.19, p<.01; η2=.09), 
but no Group × Time interaction (F(1,141)=1.96, p=.16; η2=.04).  A 3 Group (60%, 85%, 110%,) 
× 2 Time (baseline, 24 hr post-exercise) ANOVA comparing the three separate exercise groups 
again revealed no significant Group × Time interactions (F(2,106)=0.95, p=.39; η2=.09).  No 
main effects of Sex and no Sex × Time interactions were identified for any of the IL-6 analyses 
(p >.05). 
 
Correlations 
 
To explore the association between the acute response to eccentric exercise and the response to 
vaccination, a series of Pearson correlations were conducted.  Analyses were performed only 
within the exercise group as participants in the control group showed, as expected, minimal 
changes in arm circumference and pain scores.  As expected, Borg scores obtained immediately 
after the exercise bout were associated with CK change from baseline to 24 hr post-exercise 
(p=.01), forearm percentage change (p = .019), arm pain at rest (p< .01) and arm movement pain 
(p< .01).  However, no other significant correlations were observed and, notably, no relations 
were observed between antibody change scores and either CK change, IL-6 change, limb 
circumference, pain (resting and movement) or Borg scores.   
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Table II.  Percentage change (mean ± SD) in upper arm and forearm limb circumference from baseline to immediately post-task; 
and upper arm pain immediately post-task either at rest or during a movement replicating the action of the exercise tasks. 
 
 
 
 
a
 significantly different from control group (p<.05) 
b
 significantly different from 60% exercise group (p<.05) 
 
 Control 
60% 
exercise 
85% 
exercise 
110% 
exercise 
Group Effects 
Change in upper arm limb 
circumference (%) 
−0.15 ± 0.45 0.64 ± 1.49 0.92 ± 2.56 1.85 ± 2.49a b F(3,145)=6.40, p<.01, η2=.12 
Change in forearm limb 
circumference (%) 
−0.20 ± 1.12 1.37 ± 1.61a 2.52 ± 2.06a 3.17 ± 3.85a b F(3,146)=14.86, p<.01, η2=.23 
Resting arm pain immediately 
post-task (1-100) 
1.37 ± 1.24 8.33 ± 15.55a 9.84 ± 13.80a 13.64 ± 17.37a F(3,146)=5.09, p<.01, η2=.10 
Movement arm pain 
immediately post-task (1-100) 
2.66 ± 2.91 15.08 ± 15.62a 25.25 ± 18.47a b 25.74 ± 21.52a b F(3,146)=15.53, p<.01, η2=.24 
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Figure II.  Plasma CK (top; U/l) activity and IL-6 (bottom; pg/ml) concentrations in each 
experimental group at baseline and at 24 hr post-exercise. 
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DISCUSSION 
 
This study evaluated the adjuvant effect of a single bout of eccentric exercise on the antibody 
response to influenza vaccination, and whether the efficacy of this intervention was modulated by 
the intensity of the exercise bout.  Replicating prior research, eccentric exercise enhanced the 
antibody responses to the least immunogenic of the three influenza strains (B/Florida) in both 
men and women.  In addition, exercise also augmented the response to the A/Uruguay strain, 
although this was apparent only in men.  Antibody responses to the most immunogenic strain, 
A/Brisbane, showed no effect of the intervention.  Varying the eccentric exercise intensity did not 
influence intervention efficacy. 
 
These results provide further evidence that eccentric exercise is particularly effective at 
augmenting the immune response when the antibody response to the vaccination is weak.  By 
using a reduced dose influenza vaccine, a poorer immune response was elicited in a healthy 
population, particularly to two of the three vaccination viral strains (A/Uruguay, B/Florida).  As 
anticipated, it was these strains that demonstrated immuno-enhancement by the exercise 
intervention.  The third influenza strain (A/Brisbane) induced higher antibody responses and 
there was no effect of exercise found.  These findings are consistent with previous research 
showing that exercise-induced augmentation of antibody responses was only observed when the 
control group had relatively poor responses (Edwards et al. 2006; Edwards et al. 2007; Edwards 
et al. 2008).  Taken together, the findings from these studies suggest that exercise is effective in 
augmenting otherwise relatively poor immune responses. 
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Another key aim of this study was to evaluate whether the intensity of the exercise bout 
modulated the efficacy of the eccentric exercise intervention.  Edwards et al (2007) showed that 
eccentric exercise at 85% 1RM enhanced immune responses to influenza vaccination; the present 
study compared a lower (60%) and higher (110%) exercise intensity to evaluate the effect of this 
modulation on adjuvant efficacy.  As anticipated, a number of physiological differences were 
observed between the three exercise groups after the exercise bout.  For example, self-reported 
arm pain and change in limb circumference exhibited dose-dependent responses, where the 
greatest increases were observed in participants exposed to the highest intensity exercise.  Indeed, 
CK also showed the highest increase in the high-intensity group.  However, despite these 
physiological differences, there was no association between the extent of these changes and the 
antibody response to vaccination.  For example, contrary to previous research (Edwards et al. 
2006), there was no association between the antibody response to vaccination and the IL-6 
response to exercise, measured at 24 hr post-exercise.  It may be that plasma levels of these 
markers did not accurately represent actual intramuscular damage and inflammatory status 
following eccentric exercise, as has been shown previously (Jonsdottir et al. 2000).  More likely, 
however, is the possibility that the changes in plasma IL-6 reflect the nature of the exercise bout 
being conducted.  In this study, eccentric exercise induced relatively small changes in IL-6, 
whereas in the previous study a concentric based (cycling) protocol was used (Edwards et al. 
2007), and changes in plasma IL-6 are typically higher following this type of exercise.  
Importantly, it should also be noted that the timings of IL-6 measurement also differed between 
these two studies; in this study IL-6 was measured post-vaccination, whereas in the previous 
study it was measured before vaccine administration (Edwards et al. 2007).  Further, it is also 
possible that the IL-6 response to exercise was confounded by an additional IL-6 response to 
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vaccination (Tsai et al. 2005); the observed increase in IL-6 even in the control group suggests 
that this is a plausible explanation.  Finally, it is possible that the physiological measures taken 
may not accurately represent the peak response to the exercise.  For pragmatic reasons, they were 
assessed either immediately post-exercise at the time of vaccination (pain, limb circumference), 
or 24 hours later (IL-6, CK), whereas it is well established that greatest inflammatory responses 
are observed in the damaged skeletal muscle tissue up to 48 hr after muscle-damaging exercise 
(Proske and Morgan, 2001).  It remains possible that the magnitude of the later peak could relate 
more accurately to the antibody response which is developing during this time (Cox et al. 1994).  
This could be addressed in future studies by conducting a more detailed kinetic profile of the 
inflammatory response to the exercise. 
 
Given that enhancement of antibody responses to vaccination occurred independently of exercise 
intensity, it is important to consider potential mechanisms.  There is evidence that muscular 
contractions are associated with a temporary increase in lymph drainage around the site of 
exercised muscle tissue (Havas et al. 1997) which could subsequently enhance immune cell 
transport to and from the site of antigen administration (Swartz et al. 2008).  It is possible, 
therefore, that simply performing the eccentric exercise is sufficient to enhance this process.  
Alternatively, a threshold effect of exercise may exist whereby some degree of exercise enhances 
antibody responses but higher intensities do not cause further augmentation; it may be that this 
intensity threshold may be lower than the exercise intensities used in this study.  Future research 
should investigate the mechanisms underpinning the adjuvant potential of exercise to help clarify 
this issue. 
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In summary, eccentric exercise improved the antibody response to a reduced dose influenza 
vaccine.  The reduced dose vaccine produced weak antibody responses to the B/Florida and 
A/Uruguay strains, and the intervention was effective in both cases, increasing the response in 
both men and women for B/Florida and in men only for A/Uruguay.  The A/Brisbane strain 
produced the most robust immunogenic response and no adjuvant effects were found. These 
findings add to previous research, and support the hypothesis that acute behavioural adjuvants 
enhance weak immune responses to vaccination.  Given this, future research should consider 
whether less immunogenic vaccines which currently require multiple doses can be enhanced by 
acute behavioural stress, and whether this intervention could augment immune responses in the 
immuno-comprised, such as the chronically stressed (Burns et al. 2003), the elderly (Goodwin et 
al. 2006) and HIV patients (Kroon et al. 1994). 
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CHAPTER FOUR 
 
THE INFLUENCE OF VACCINE ADMINISTRATION SITE  
ON THE EFFICACY OF ECCENTRIC EXERCISE  
AS AN ADJUVANT TO HEPATITIS B VACCINATION  
IN YOUNG ADULTS 
 
ABSTRACT 
 
Behavioural interventions, such as acute exercise, have been shown to improve responses to 
poorly immunogenic vaccines.  It has been speculated that eccentric exercise involving muscles 
close to the site of vaccine administration induces a pro-inflammatory local environment that is 
beneficial to the specific antibody response.  However, eccentric exercise also induces 
immunological changes at a systemic level, which raises the possibility that the adjuvant effect 
could be more widespread.  The aim of the current study was to determine whether exercise 
induced changes in the antibody response are mediated via local or systemic effects of exercise.  
Seventy-eight healthy participants (39 men) were randomly assigned to an exercise group (n = 
59) or a resting control group (n = 19).  The exercise group performed 50 repetitions of the 
eccentric portion of both the bicep curl and lateral raise movements, in the non-dominant arm, at 
an intensity eliciting 85% of the participant’s concentric one repetition maxima.  All participants 
then received a hepatitis B vaccination; this vaccine was chosen because a single dose induces a 
relatively poor antibody response in humans.  Thirty-one exercise participants received the 
hepatitis B vaccine into the non-dominant (exercised) arm and twenty-nine exercise participants 
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received the vaccine into the dominant (resting) arm.  Anti-hepatitis antibody levels were 
measured at baseline and 28 days post-vaccination as indicators of the humoral response.  Anti-
hepatitis B antibodies increased from baseline to 28 days, but exercise had no effect on these 
responses, regardless of the site of administration.  These findings may indicate that eccentric 
exercise has a limited adjuvant effect on the primary antibody response to vaccination.   
 
INTRODUCTION 
 
Acute behavioural interventions, such as exercise and psychological stress, can improve the 
immune response to a variety of vaccinations (Edwards et al. 2006; Edwards et al. 2007a; 
Edwards et al. 2008).  For example, a bout of eccentric arm exercise performed prior to influenza 
vaccination improved the antibody response to influenza vaccination in women.  Specifically, 
exercised women showed enhanced responses against the A/Wyoming and B/Jiangsu strains of 
influenza compared with women in the control group, who showed poor responses to these 
strains.  The other strain, A/Fujian, induced relatively robust responses in the control group and 
no further enhancement by exercise was found.  These results suggest that exercise may enhance 
poorer antibody responses, but have no effect on normal robust immune responses.   
 
This account is supported by two large-scale randomised control trials.  The first study revealed 
that exercise had no effect on the immune response to influenza vaccination when the vaccine 
contained relatively immunogenic strains (Chapter Two).  In the second study, a half-dose 
influenza vaccine was used to reduce the immunogenicity of the vaccine (Chapter Three).  
Results indicated that exercise enhanced the antibody response to the B/Florida strain in men and 
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women, and to A/Uruguay in men only.  In these cases, relatively poor responses were exhibited 
by the relevant control group suggesting that exercise augmented these otherwise weakened 
responses.  Again, no effect of exercise was observed in the most immunogenic strain, 
A/Brisbane.  Taken together, we hypothesise that eccentric exercise may enhance antibody 
responses to poorly immunogenic vaccine strains.  To investigate this hypothesis further, this 
study investigated the effects of exercise on the immune response to a single hepatitis B vaccine. 
 
Hepatitis B virus (HBV) is a highly infectious DNA virus responsible for infecting approximately 
two billion people worldwide and killing up to 600,000 individuals each year 
(http://www.who.int).  Currently, vaccination is the primary method of preventing HBV 
infection; however, a single vaccine induces poor immunogenic responses and, as a consequence, 
a primary vaccination, followed by at least two ‘booster’ secondary doses, is recommended.  This 
lengthy and uneconomical schedule has led to widespread interest in the development of 
adjuvants used to enhance immune responses (Sanyal and Shi, 2009).   
 
Although there is now considerable evidence of the utility of acute-behavioural stress as an 
adjuvant to vaccination in the literature (Edwards et al. 2007b); Campbell et al. in submission), 
the underlying mechanisms underpinning these adjuvant effects remain unclear.  Given this, one 
important factor to consider is whether the adjuvant effects of exercise are driven by mediators 
within the local damaged muscle tissue or from systemic inflammatory mediators released in 
response to exercise.    
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Unaccustomed eccentric exercise causes local muscle damage to skeletal muscle by disrupting 
internal structures in the muscle fibres (Proske and Morgan, 2001).  This physical damage 
induces an inflammatory response in the muscle characterised by oedema, pain and increased 
immunological signalling and leukocyte infiltration (Peake et al. 2005).  This pro-inflammatory 
environment may facilitate antigenic identification and clearance.  For example, there is evidence 
to suggest that stressed skeletal muscle cells release danger signals that activate dendritic cells 
(Gallucci et al. 1999; Shi and Rock, 2002).  Further, muscular contractions from exercise are 
associated with a temporary increase in lymph drainage around the site of exercised muscle tissue 
(Havas et al. 1997) which could subsequently enhance immune cell transport to and from the site 
of antigen administration (Swartz et al. 2008).  Together, it appears that localised muscle damage 
and increased lymph drainage arising from eccentric exercise may offer an environment which 
can enhance the immune response to vaccination.  For this reason, one group in this study were 
administered a single hepatitis B vaccine into eccentrically-exercised muscle tissue. 
 
However, eccentric exercise also induces a number of systemic alterations which could lead to an 
augmented antibody response to vaccination.  For example, during this type of exercise, it has 
been demonstrated that circulating levels of inflammatory mediators, such as plasma IL-6 
(Campbell et al. in press) and a host of other pro-inflammatory cytokines (Peake et al. 2005), are 
elevated above resting levels.  Elevated concentrations of cytokines, such as IL-6, have 
previously been implicated in enhancing vaccine responses (Krakauer, 1995; Lee et al. 1999).  It 
is, therefore, possible that increased levels of these pro-inflammatory mediators in the systemic 
circulation, stemming from eccentric exercise-induced muscle damage, could be a mechanism for 
augmented immune responses seen previously (Edwards et al. 2007a; Campbell et al. in press).  
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A recent study has shown that completion of concentric (cycling) exercise and / or acute 
psychological stress (pressurised mental arithmetic test) leads to both an increase in systemic IL-
6 and an enhanced antibody response to vaccination (Edwards et al. 2006); the extent of the IL-6 
response was also associated with the antibody response at six weeks post-vaccination .  This 
suggests that elevations of inflammatory mediators in the systemic circulation may be a crucial 
component in the adjuvant effect of acute behavioural stress.  Therefore, in this study, a second 
exercise group received the vaccine in the non-exercising arm.  If both exercised groups were to 
demonstrate an augmented response to the vaccination, this would support a “systemic” adjuvant 
mechanism.  In contrast, if any enhancements were limited to the group receiving their 
vaccination directly into the exercised arm, a more local mechanism would be indicated.     
 
In summary, the primary aim of this study was to investigated the effects of eccentric exercise on 
the IgG antibody responses to a single dose hepatitis B vaccine.  IgG antibodies were measured at 
baseline and at 28 days post-vaccination as this represents the peak IgG response to primary 
vaccination (Odinsen et al. 2007).  A further aim of this study was to investigate whether immune 
augmentation was mediated via local or systemic mechanisms, by comparing the antibody 
responses of exercised participants who were vaccinated in either their exercised or non-
exercised arm.   
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METHODS 
 
Participants 
 
Seventy-eight healthy, physically active students (39 men) were recruited from the University of 
Birmingham, and seventy-six completed this study (mean ± SD age:  21.08 ± 1.6 years; body 
mass index:  22.72 ± 2.3 kg/m2).  None of the participants had received the Hepatitis B vaccine 
previously, or had reported symptoms indicative of the condition in the past.  Exclusion criteria 
included smoking, a history of immune or cardiovascular disease, current acute infection or 
illness, pregnancy or suspected pregnancy, a history of vaccine-related allergies or side effects, 
and use of prescription medication (excluding the contraceptive pill) within one month of 
participation.  In addition, none of the participants reported having performed any resistance 
training in the 6 months prior to testing.  All participants were instructed to abstain from vigorous 
exercise and over-the-counter medication for at least 24 hr, alcohol for at least 12 hr, and food or 
caffeine for at least 2 hr prior to each session, and to refrain from over the-the-counter medication 
for up to 24 hr after the exercise / control task.  All participants gave written informed consent, 
and the study was approved by the South Birmingham Local Research Ethics Committee.  They 
were paid ten pounds or given student research hours upon completion of the study.   
 
Procedure 
 
Participants were pseudo-randomised, maintaining an even sex distribution, into either exercise 
group A (n=31), exercise group B (n=28), or a non-exercise control group (n=19).  Groups did 
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not differ for stressful life events exposure, perceived stress and health behaviours (data not 
reported here); these factors have been associated with augmentation of antibody responses 
(Burns et al. 2003; Cohen et al. 2001).  In the first session, height and weight were determined, 
and a test of maximal muscle strength was conducted.  After 7 days or more, participants returned 
to the laboratory for session 2, between 1000 hr and 1200 hr, for baseline blood sampling.  Blood 
samples were taken from an antecubital vein in the dominant arm following a 20 min rest period.  
Next, participants completed either the eccentric exercise task with their non-dominant arm 
(exercise groups) or remained resting quietly for 25min (control group).  Participants then 
returned to the laboratory 6 hr after completion of the morning session, between 1600 hr and 
1800 hr; this delayed administration allows development of the response to the eccentric exercise 
task (Edwards et al. 2007a; MacIntyre et al. 2001).  A nurse administered a Hepatitis B (Engerix 
B, GlaxoSmithKline, Batch number AHBVB253AB) and a Meningococcal ACWY (ACWY 
Vax, GlaxoSmithKline, Batch number A73FA135A) vaccine via intra-muscular injection into 
opposite deltoid muscles (only data from the hepatitis B vaccine is presented here due to assay 
problems associated with the meningococcal assay).  One group received the Hepatitis B vaccine 
into the non-dominant (exercised arm group) arm and the Meningococcal ACWY vaccine into 
the dominant (rested) arm, whereas the opposite group (non-exercise arm group) received the 
alternate configuration.  The control group were also randomly matched for arm of vaccination; 9 
participants received the Hepatitis B vaccine into the non-dominant arm and the Meningococcal 
ACWY vaccine into the dominant arm, whereas the other 10 participants in the control group 
received the vaccines into the opposite arms.  Participants returned to the laboratory after one day 
to provide a blood sample for indirect measurement of muscle damage (plasma CK), and at 28 
days post-vaccination for IgG antibody determination. 
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Exercise Task   
 
The exercise protocol was adapted from a previous study protocol (Edwards et al. 2007a).  In 
brief, following the determination of maximal muscle strength (1 Repetition Maxima:  Bicep 
Curl:  12.08 ± 4.4 kg; Lateral Raise:  8.61 ± 3.0 kg), participants performed the eccentric portions 
of the bicep curl and lateral raise exercises, contracting the biceps brachialis and deltoid muscles 
of the non-dominant arm, respectively.  In both exercises, they were asked to lower the dumbbell 
in a controlled manner.  All participants performed 50 repetitions of each muscle action at an 
intensity eliciting 85% of their individual 1RM (6 sets of 7 repetitions followed by 2 sets of 4 
repetitions).  They completed a set of lateral raises, rested 30 s, completed a set of bicep curls, 
and rested 60 s before the next set of lateral raises.  The task lasted approximately 25 min. 
 
Blood sampling   
 
Blood was collected in a 10 ml vacutainer containing potassium ethylene diaminetetraacetic acid 
(K3EDTA) (Becton-Dickinson, UK) at baseline and 24 hr post-vaccination.  Tubes were stored 
on ice until centrifugation (3400 g for 10 min at 1 °C) and plasma was stored at −80 °C for later 
assessment of creatine kinase.  Blood serum was collected in a plain 10 ml vacutainer and 
allowed to clot for 1 hr at room temperature; and following centrifugation (3400 g for 5 min at 21 
°C), was stored at −20 °C for later antibody titre determination. 
 
102 
 
 
Hepatitis B Antibody Assay 
 
Serum was assayed for levels of immunoglobulin (IgG) antibodies against Hepatitis B surface 
antigen using a specially developed in-house Luminex assay.  The protocol was based on assays 
developed by others (Lal et al. 2004; Odinsen et al. 2007).  The first stage of the assay involved 
adhering the specific antigen to identifiable microspheres.  Recombinant Hepatitis B surface 
antigen (HepBsAg) (IBT Systems, Germany) was separated from tris buffered saline (TBS) using 
a buffer exchange technique (SuperSpin™ Desalter, BioToolomics, UK) and re-suspended in 
storage buffer (phosphate buffered saline (PBS) with 1 % bovine serum albumin (BSA), 0.05 % 
NaN3 and 0.05 % Tween 20; all Sigma Alrich).  HepBsAg was then coupled to activated 
carboxylated microspheres (region 43).  The microspheres were then activated using activation 
buffer (NaH2PO4) containing 5 mg / ml EDC (Sigma-Aldrich) and 5 mg / ml Sulpho-NHS 
(Sigma-Aldrich).  The solution was incubated on a rotator for 20 min at room temperature in the 
dark.  Microspheres were washed with PBS by centrifugation and re-suspended in 125 µl of 
HepBsAg solution, and incubated for 2 hr at RT in the dark.  Following this, the microspheres 
were washed twice with wash buffer (PBS, 0.05 % Tween 20) and stored in 100 µl storage buffer 
at 4 °C in the dark.   
 
The second part of the assay involved measuring the concentration of specific antibody using the 
coated microspheres.  Hep B IgG standard (HepBQuin, Sanquin, NL; 100 IU / ml) was diluted at 
1:3000 in diluent buffer (PBS, 1 % BSA and 0.05 % NaN3) and a 7 point curve serially diluted 
1:3 was generated.  Serum samples were diluted 1:100 in diluent buffer.  Samples and standards 
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(50 µl) were incubated with 2500 beads per well for 1 hr at room temperature on a plate shaker.  
After 5 washes (PBS with 1 % BSA, 0.05 % NaN3 and 0.05 % Tween 20), contents were 
incubated with IgG-PE mouse anti-human secondary antibody (Invitrogen Corp, CA, USA) (100 
µl, 1:200) for 40 minutes on a plate shaker at room temperature.  Microspheres were washed and 
resuspended  in 125 µl of wash buffer and read on a Luminex machine (Luminex Corp, TX, 
USA), programmed to collect data for 100 microspheres per well.  Acquisition software (BioPlex 
Software Manager (version 4), BioRad Labs, CA, USA) was used to generate serotype antibody 
concentrations from a five parameter logistic curve fit.  Serum IgG levels are reported as IU / l.  
 
Creatine kinase assay 
 
Plasma creatine kinase (CK), an indirect marker of muscle-damage, was measured using a semi-
automated analyser (COBAS MIRA S-plus, ABX, UK) and diagnostic reagents (ABX 
diagnostics, UK).  CK samples were analysed in triplicate, and coefficient of variations for CK 
were calculated as <2%. 
 
Limb circumference, pain and perceived exertion 
 
Muscle soreness was assessed using a visual analogue scale (Melzack, 1987) with anchors of 0 
(no pain) and 100 (worst possible pain), to indicate an overall pain rating regarding the non-
dominant arm.  These measures were completed by all participants immediately, 6 hr 
(immediately prior to vaccination), and 24 hr after the task.  Change in upper arm circumference 
was used to quantify the amount of swelling in the non-dominant arm from pre-task baseline to 
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immediately post-task, and at 6 hr post-task.  Measurements were taken in an unblinded manner 
using tape measure at the point of flexed maximal circumference of the upper arm and, 5 cm 
below the elbow crease in the inside of the forearm.  After locating the site of measurement, 
participants let their arm hang, relaxed, by their side for all measurements.  Measurement sites 
were marked in two places at the first testing session to ensure consistent placement of tape 
measure.  Exercise group participants also provided a rating of perceived exertion (Borg, 1970) 
immediately after the task using a 15-point scale (6= “no exertion at all”, 20= “maximal 
exertion”), immediately after the task. 
 
Statistical analysis 
 
Due to the skewed distributions of the antibody titres, analyses were performed on LOG10 
transformed values.  Previous studies have found sex differences in intervention efficacy 
(Edwards et al. 2006; Edwards et al. 2007a; Edwards et al. 2008a) and, as a result, sex was 
entered as a between-subject factor in all initial analyses.  If no sex effects were found at this 
stage, it was excluded from further analyses.  All analyses were conducted using ANOVA 
(antibody titres; CK; pain; percentage change in limb circumference).  In each analysis, a 
combined exercise group, with both exercise sub-groups collapsed, was initially compared with 
the control group.  Individual exercise groups were then compared with control, followed by a 
comparison between exercise groups.  Effect sizes are represented by eta-squared (η2).  
Differences in degrees of freedom reflect occasional missing data. 
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RESULTS 
 
Antibodies 
 
Figure I displays the Log transformed mean IgG Hepatitis B antibody levels at baseline and at 28 
days post-vaccination for the exercise groups combined and the control group.  A 2 Group 
(combined exercise groups, control) × 2 Sex (male, female) × 2 Time (baseline, 28 days post-
vaccination) ANOVA revealed a main effect of Time (F(1,67)=4.78, p=.03, η2=.07), indicating 
that antibodies against Hepatitis B increased from baseline to 28 days.  However, no Group × 
Time effect (F(1,67)=0.20, p=.66, η2<.01) was observed.  Similarly, no Sex × Time 
(F(1,67)=0.86, p=.77, η2<.01), and no Group × Sex × Time (F(1,67)=0.31, p=.86, η2<.01) effects 
emerged.  Similarly, separate analyses comparing each exercise group to the control group 
revealed no significant Sex × Time, Group × Time, or Group × Sex × Time interactions.  Finally, 
there were no significant differences in the responses between the two exercise groups (ps all 
>.2).  Further analysis revealed that 6 participants, split equally (3 vs 3) between exercise and 
control groups, showed the WHO recommended response (>100 IU / L) to acquire immunity to 
the vaccine. 
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Figure I.  Mean (± SEM) hepatitis B antibody levels pre-vaccination and at 28 days post-
vaccination for participants in the control group and exercise groups (combined). 
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Limb circumference and arm pain 
 
A 2 Group (exercise groups combined, control) × 2 Sex (male, female) ANOVA comparing 
percentage change limb scores from baseline to post-task showed, as anticipated, an overall effect 
of Group for forearm  (F(1,71)=19.90, p<.01, η2=.22) and upper-arm (F(1,71)=17.13, p<.01, 
η
2
=.19) circumferences; (Figure II, top).  ANOVAs showed that both exercise groups manifested 
higher bicep and forearm circumference percentage changes in comparison to control (all ps 
<.05).  No differences were observed between the two exercise groups, and no Sex effects were 
observed (all ps>.05). 
 
Similarly, a 2 Group (combined exercise groups, control) × 2 Sex (male, female) ANOVA 
comparing self-reported arm pain scores immediately post-task revealed significant Group effects 
(F(1,72)=41.16, p<.01, η2=.36) (Figure II, bottom).  ANOVAs showed that pain was elevated in 
both exercise groups compared with control (all ps <.05); no differences were observed between 
exercise groups and no Sex effects were observed (p>.05). 
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Figure II.  Mean (± SEM) percentage change in upper-arm and forearm limb circumference from 
baseline to immediately post-task (top), and self-reported arm pain immediately post-exercise for 
both the exercise and control groups (bottom).  * Indicates significant difference in comparison to 
control (P < .05). 
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Creatine kinase 
 
A 2 Group (combined exercise groups, control) × 2 Sex (male, female) × 2 Time (baseline, 24 hr 
post-task) ANOVA revealed significant Group × Time effects (F(1,60)=3.90, p=.05, η2=.06).  
These results indicate that exercise caused CK to increase from baseline to 24 hr post-task 
(Figure III).  A series of ANOVAs revealed that the exercise arm group (hepatitis B vaccine into 
the exercised arm) had significantly higher CK than control (F(1,36)=3.94, p=.05, η2=.10), 
whereas the other group (non-exercised arm group) showed a close to significant elevation in CK 
compared with control (F(1,35)=3.56, p=.07, η2=.09); no differences were observed between 
exercise groups (p>.05).   
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Figure III.  Mean (± SEM) plasma CK (U / l) activity s in the control and exercise groups 
(combined) at baseline and at 24 hr post-exercise. 
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DISCUSSION 
 
 
The primary aim of this study was to investigate whether an acute bout of eccentric arm exercise 
could enhance the immune response to hepatitis B vaccination in healthy young adults.  As 
previous studies have demonstrated that eccentric exercise improved the immune response to 
poorly immunogenic vaccines (Edwards et al. 2007a; Chapter Two; Chapter Three), it was 
hypothesised that the antibody response to a single hepatitis B vaccination would be augmented 
by exercise.  However, although the hepatitis B vaccine induced a modest increase in anti-HBV 
antibodies, the exercise group antibody response to vaccination was not different to control.  As a 
consequence, it was not possible to investigate the secondary aim of this study, namely, to 
determine whether any adjuvant effects of exercise are mediated by vaccinating into localised 
damaged muscle or by systemic changes produced from the exercise bout. 
 
Manipulation checks confirmed that eccentric exercise induced considerable physiological 
alterations.  Participants in the exercise groups exhibited increases in their upper and forearm 
limb circumference, as well as greater arm pain, in comparison to control participants.  Further, 
CK, an indirect marker of muscle damage, increased in exercised participants compared with 
controls.  These later findings are consistent with previous studies by our group (Edwards et al. 
2007a; Chapter Two, Chapter Three), and confirm that exercise induced the desired effect in 
terms of  muscle damage and inflammation.   
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Given this, it is important to consider alternative reasons why eccentric exercise had no effect on 
antibody responses.  Firstly, it should be noted that there was very low variability in the antibody 
response to the vaccine.  The overall mean increase in anti-HBV antibodies at 28 days post-
vaccination was driven mainly by a small number of participants (spread equally among 
experimental groups), who responded reasonably well to the vaccine; the majority showed no 
antibody response.  This is broadly in line with the results of another study showing a low 
number of sero-converters after a single vaccination (Glaser et al. 1992).  In our data, the 
dichotomous distribution somewhat disguised the otherwise low variability in the antibody 
responses; this lack of variability may explain, to some extent, the null findings.   
 
This aside, other mechanisms should be investigated.  For example, in this study, hepatitis B was 
chosen to investigate whether exercise enhances poorer antibody responses, whereas most 
previous studies have used seasonal influenza vaccines (Edwards et al. 2007a; Chapter Two; 
Chapter Three).  These vaccines differ in terms of the probability of previous exposure to the 
antigen.  Hepatitis B is likely to be a novel antigen to young, healthy adults with no previous 
history of vaccination or infection.  In contrast, most individuals have some level of baseline 
immunity against H1N1 and H3N1 influenza viruses, due to cross-reactivity after previous 
exposure against similar seasonal strains of the virus.  Given that eccentric exercise enhanced 
responses to influenza, but not hepatitis B, vaccines, it is possible that eccentric exercise more 
effectively enhances secondary immune responses.  Indeed, it has been shown in animals that a 
single bout of intense exercise prior to human serum albumin (HSA) vaccination did not affect 
the primary antibody response, but did enhance the subsequent secondary response to a booster 
HSA vaccine in mice, compared with non-exercise controls (Kapasi et al. 2000).  The possibility 
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that behavioural adjuvants are beneficial to secondary, but not primary, antibody responses 
warrants further attention in future research.  This could be addressed by measuring the effects of 
exercise on the immune response to a full course of hepatitis vaccines. 
 
Another possible explanation for this unexpected finding is that individual responsiveness to 
hepatitis B vaccination is limited by factors that are not impacted by our intervention.  There is 
considerable evidence that the response to hepatitis B vaccination is particularly influenced by 
inherited genetic factors, notably by the ability of T cells to recognise antigen via human 
leukocyte antigen (Egea et al. 1991).  As a consequence of large variation in HLA type, the 
variability in the number of people responding to the vaccine is high.  It is plausible, although 
speculative, that where genetic factors are paramount in determining responsiveness, a 
behavioural adjuvant may be less effective.   
 
In summary, eccentric exercise did not improve the immune responses to a single dose hepatitis 
B vaccine.  These findings contrast with previous findings using the influenza vaccination, and 
reveal some limits of the eccentric exercise enhancement effect.  The results raise the possibility 
that the adjuvant effects of eccentric exercise may be limited to secondary antibody responses.  
Finally, future studies should readdress whether immune augmentation is mediated via local or 
systemic mechanisms, using a vaccine, such as influenza, in which the exercise intervention has 
demonstrated more consistent benefits for antibody responses.    
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CHAPTER FIVE 
 
GENERAL DISCUSSION 
 
SUMMARY 
 
The aim of this thesis was to investigate the effects of eccentric exercise on the immune response 
to vaccination.  Following prior research in humans proposing eccentric exercise as a potential 
adjuvant to vaccination (Edwards et al. 2007), this thesis further investigated the efficacy of this 
intervention through the completion of three large randomised control studies.  The first study 
(Chapter Two) investigated the effects of eccentric exercise on the antibody and cell-mediated 
responses to influenza vaccination in healthy young adults, and whether the timing of the exercise 
affected the efficacy of the intervention.  As anticipated, all 155 participants exhibited robust 
antibody responses to each of the trivalent strains contained within the vaccine.  Exercised 
participants exhibited increases in limb circumference, self-reported muscle pain and CK, in 
comparison to a resting control group.  However, results indicated that exercise had no effect on 
the antibody or cell-mediated responses to the vaccine.  The exercise timing manipulation 
revealed that, despite the distinct physiological differences observed between the exercise groups, 
exercising immediately, 6 hr or 48 hr prior to vaccination had no effect on the antibody or cell 
mediated responses to the vaccine.   
  
The second study (Chapter Three) investigated the effects of eccentric exercise on the immune 
response to a half-dose influenza vaccine, and whether the efficacy of this intervention was 
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modulated by the intensity of the exercise bout.  Compared with the control group, exercise 
enhanced the antibody response to the least immunogenic of the three strains (B/Florida).  In 
addition, the exercise groups showed an augmented response to the A/Uruguay strain compared 
with control; however, this effect was observed in men only, who showed poorer responses than 
women.  The intervention had no effect on the antibody responses to the most immunogenic 
strain, A/Brisbane.  Exercising at 60 %, 85 % and 110 % of IRM induced distinct physiological 
changes in each of the exercise groups, with the most intensive exercise group exhibiting higher 
levels of CK, self-reported arm pain, and percentage change in limb circumference.  However, 
despite these distinctive group differences, no association between exercise intensity and 
antibody responses was observed.   
 
The final study (Chapter Four) investigated the effects of eccentric exercise on the immune 
response to a single hepatitis B vaccination, and whether the efficacy of this intervention was 
influenced by the site of vaccine administration.  As anticipated, anti-hepatitis B antibodies 
showed a small increase from baseline to 28 days, but contrary to our hypothesis, it was found 
that exercise had no effect on these responses.   
 
CLINICAL APPLICATION OF ECCENTRIC EXERCISE 
 
A key aim of the studies compiled in this thesis was to identify the optimal strategy for the 
implementation of eccentric exercise as an adjuvant to vaccination in a clinical setting.  Prior to 
my research, only one study had investigated the role of eccentric exercise in improving vaccine 
responses (Edwards et al. 2007).  In that study, a beneficial effect of exercise, at an intensity of 
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85% of 1RM, was found when the vaccine was administered at 6 hr post-exercise.  This timing 
and intensity was selected on the basis of sound theoretical hypotheses, but it was important to 
also now test them empirically by comparing different protocols.      
 
Issue of eccentric exercise timing prior to vaccination 
 
In terms of intervention timing, the model used by Edwards and colleagues did not provide the 
most practically applicable intervention due the fact participants needed to visit the laboratory on 
two occasions.  Chapter Two was designed to investigate this issue systematically by comparing 
the efficacy of the intervention when completed at differing times pre-vaccination.  However, as 
there was no overall effect of the intervention in this study, it was not possible to gain any further 
understanding of the influence of intervention timing through this study.  However, Chapter 
Three illustrated that it is possible to augment the immune response to eccentric exercise when 
the vaccine is administered immediately after the exercise bout.  This is the first time that this has 
been shown, and this finding has clear and important clinical significance.  Patients would only 
require a single visit the clinic to complete the exercise task and receive the vaccine.  This allows 
much easier practical application of the intervention and, therefore, a more efficient strategy for 
patients and practitioners by saving patient effort, increasing adherence, and reducing the burden 
of the intervention on clinic time and resources.   
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Issue of eccentric exercise intensity 
 
Exercise intensity is also an important issue in developing this intervention.  Despite the overall 
success of using 85% of 1RM in the previous study, a lesser intensity of exercise would, if 
effective, enable a more acceptable and safer intervention approach.  Chapter Three demonstrated 
that completion of an eccentric exercise task, regardless of the intensity of the bout, resulted in 
augmentation of the least immunogenic strains contained within the vaccine.  These findings 
illustrate that the lowest intensity used in that study (60 % of 1RM) appears to be just as 
efficacious in enhancing responses as higher intensity bouts of eccentric exercise (85% and 110 
% of 1RM).  Clearly, this has important practical implications and means that participants may 
not have to participate in overly-demanding exercise, resulting in increased safety and greater 
ease of use, particularly for special populations such as the elderly and the disabled.   
 
Immuno-enhancement of poorly immunogenic vaccine strains by eccentric exercise 
 
Previous research has suggested that eccentric exercise is particularly effective at enhancing the 
immune response to poorly immunogenic vaccine strains.  For example,  it has been shown that 
mice administered an immunosuppressive drug, cyclophosphamide, prior to vaccination showed 
larger antibody responses following restraint stress in comparison to control mice.  This highly 
controlled experiment provides strong evidence that acute stress can augment immune responses 
when it would otherwise be expected to be poor (Karp et al. 2000).  This has been supported by a 
number of recent studies in humans (Edwards et al. 2006; Edwards et al. 2007; Edwards et al. 
2008).  In the first of these studies, psychological stress and / or cycling exercise only enhanced 
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the antibody response to the A/Panama strain of influenza in women; this was the least 
immunogenic of the trivalent strains in the 2003/2004 northern hemisphere vaccine (Edwards et 
al. 2006).  Further, the other two strains produced relatively robust immunogenic responses and 
no effect of behavioural stress was found.  In the same study but reported elsewhere (Edwards et 
al. 2008), the antibody response to meningococcal A vaccination was enhanced by stress in men; 
once more this strain was poorly immunogenic and induced weaker responses in men in the 
control group.  Such specificity is also observed with the eccentric exercise intervention.  For 
example, eccentric exercise had no effect on the antibody response to the A/New Caledonia strain 
of influenza, which  exhibited relatively robust responses in the control group.  These findings are 
in agreement with Chapter Two in this thesis, which showed that robust antibody responses 
against all three strains in the 2007/2008 northern hemisphere vaccine were not enhanced by 
exercise.  In the same study by Edwards and colleagues, it was also shown that the antibody 
responses to two of the trivalent strains, A/Wyoming and B/Jiangsu, induced relatively weak 
responses in participants in women the control group (Edwards et al. 2007); women in the 
exercise group showed enhanced antibody responses to these strains at 6 and 20 weeks post-
vaccination.  These findings are supported in Chapter Three, which showed that the poorer 
immune responses to a half-dose influenza vaccine were enhanced by eccentric exercise in men 
and women.  The final study in this thesis investigated whether the immune response to a less 
immunogenic vaccine, hepatitis B, was enhanced by completing a bout of eccentric exercise prior 
to vaccination.  As anticipated, the administration of a single hepatitis B vaccine induced very 
weak antibody responses but, contrary to our hypothesis, these poor responses were not enhanced 
by eccentric exercise.  It is possible that the low number of sero-responders to the vaccine limited 
the possibility of any effect being observed.  It remains possible that the immune response to 
122 
 
hepatitis B vaccination is dictated by factors, such as genetics (Egea et al. 1991), that are outside 
the influence of this intervention. 
 
Taken together, the findings from this thesis suggest that, when an individual exhibits a poor 
vaccine response, behavioural stress may be an effective intervention.  Future research should 
investigate whether this protocol is effective in immunologically compromised individuals, such 
as the elderly (Goodwin et al. 2006), the chronically stressed (Burns et al. 2003), and HIV 
patients (Kroon et al. 1994). 
 
Issue of site of vaccination 
 
Chapter Four investigated whether the site of vaccine administration influenced the immune 
response to hepatitis B vaccination, following eccentric exercise.  Unfortunately, the results 
indicated that there were no measurable effects of exercise on the antibody response to the 
vaccine, meaning it was not possible therefore to investigate the differences between vaccination 
sites.  However, Chapter Three shows that vaccination directly into exercised muscle tissue can 
enhance the immune response to vaccination; from a clinical, pragmatic perspective, it may not 
be critical to understand whether this adjuvant effect is derived from changes within the local 
intra-muscular tissues or from the systemic circulation.  As such, it is suggested that future 
clinical application of this intervention should continue to vaccinate into the exercised muscle 
tissue, as this provides the advantage of a heightened inflammatory environment within the intra-
muscular tissues, as well as the pro-inflammatory benefits obtained from the systemic vasculature 
(Edwards et al. 2007).  Future research should investigate whether the efficacy of exercise as an 
123 
 
adjuvant to vaccination is altered by completing concentric or eccentric muscle type contractions. 
From a more mechanistic viewpoint, it will be important for future research to readdress this 
issue with a vaccine, such as influenza, that has been consistently demonstrated to be modulated 
by behavioural intervention.   
 
ELUCIDATING POTENTIAL MECHANISMS 
 
In addition to designing the optimal eccentric exercise intervention, each of the studies in this 
thesis provided an opportunity to elucidate some of the possible mechanisms underpinning the 
adjuvant effects of exercise.  Chapter Two investigated whether the timing of exercise 
(immediately, 6 hr or 48 hr) prior to vaccination influenced the efficacy of the immune response 
to the vaccine.  Given that many of the physiological (e.g. CK) and inflammatory processes (e.g. 
IL-6) occur at varying timescales following eccentric exercise (Peake et al. 2005), it may have 
been possible to identify a key process mediating the augmentation of immune responses.  
Unfortunately, no overall effects of eccentric exercise were found and thus, no conclusions could 
be drawn on potential mechanisms in this study.  However, given that a previous study found 
beneficial effects of eccentric exercise on the immune response to influenza vaccination, 
administered at 6 hr post-exercise, and the study contained in Chapter Three found that eccentric 
exercise enhanced the antibody response to influenza vaccination administered immediately post-
exercise, it would seem that the timing of vaccination is not key in mediating these responses.  
This may be because antibody responses to vaccination do not occur immediately, but instead 
develop over the hours and days following vaccination.  As such, there may be a considerable 
window of opportunity for exercise to have a beneficial effect on antibody response to 
124 
 
vaccination.  More direct mechanistic studies, measuring the extent of the responses of the 
different potential mediators, will therefore be required to address this issue further.   
 
Chapter Three also investigated whether the intensity of exercise (at 60%, 85% or 110% IRM) 
influenced the efficacy of the antibody response to a half-dose influenza vaccine.  As there is 
greater muscle damage with more intense exercise, an effect of intensity on the intervention 
efficacy may indicate that the degree of muscle damage, and therefore inflammation, is key.  
Although distinct physiological differences were observed between the groups, in factors such as 
plasma CK, there was no difference between the groups in terms of antibody response.  Further, 
no association was found between the individual extent of the observed physiological damage 
and the antibody response to the vaccine within the combined exercise groups.  It is possible that 
a threshold effect exists, whereby some degree of exercise causes an enhancement of immune 
responses, but more intense exercise does not further augment these responses.  Alternatively, it 
is possible that the degree of inflammation is not the main mechanism underlying this effect.  For 
example, there is evidence to suggest that muscular contractions are associated with a temporary 
increase in lymph drainage around the site of exercised muscle tissue (Havas et al. 1997).  In this 
study, radioactively labelled HSA, injected into the muscle, was cleared more quickly following 
exercise, compared with rest.  It is possible, therefore, that exercise could subsequently lead to 
enhanced immune cell transport from the site of antigen administration via this altered lymph 
fluid dynamics.  In this case, it would be hypothesised that performing some degree of eccentric 
exercise is sufficient to enhance antigenic transport to the lymph nodes where recognition by 
lymphocytes takes place.  It would be interesting to measure this more directly in future studies. 
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The role of IL-6 
 
Chapters Two and Three in this thesis investigated whether the concentration of plasma IL-6 
following exercise was associated with the immune response to vaccination.  IL-6 was chosen as 
it has been shown in a previous study that completion of concentric exercise or acute 
psychological stress leads to both an increase in systemic IL-6 and an enhanced antibody 
response to vaccination.  Indeed, the extent of the IL-6 response was also associated with the 
antibody response at six weeks post-vaccination (Edwards et al. 2006).  Elevated concentrations 
of pro-inflammatory cytokines, such as IL-6, have been implicated in enhancing vaccine 
responses (Krakauer, 1995; Lee et al. 1999).  For example, higher mean levels of circulating IL-6 
were found in the sera of vaccinees with good antibody responses than in the sera from non-
responders, from 7 days prior to vaccination through to 63 days post-vaccination.  In addition, 
pre-immunization levels of IL-6 in serum were also higher in responders than in non-responders 
(Krakauer, 1995).  In another study, the co-administration of IL-6 gene with vaccine completely 
protected mice from a lethal challenge with influenza virus; co-administration of other cytokine 
genes was less successful (Lee et al. 1999).  Given these findings, it has been hypothesised that 
increased levels of IL-6 in the systemic circulation, stemming from eccentric exercise-induced 
muscle damage, may play a role in augmenting the immune response to vaccination (Edwards et 
al. 2007).   
 
No associations were found between the IL-6 response to exercise at 24 hr post-exercise and the 
antibody response to vaccination in either of the studies in this thesis.  It is possible that this 
discrepancy is due to the mode of exercise used.  The previous study used a concentric cycling 
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exercise, rather than an eccentric exercise intervention which is known to induce more localised 
muscle damage.  In whole body exercise, the circulating levels of IL-6 are likely to be crucial to 
any adjuvant effect.  As such, this may be why a positive association was observed in the 
previous study (Edwards et al. 2006).  In contrast, in the more localised exercise used in the 
current study, we hypothesise that it is the tissue, rather than circulating, levels of IL-6 that are 
key.  There is evidence that plasma levels of IL-6 do not always accurately represent actual 
intramuscular damage and inflammatory status following eccentric exercise (Tomiya et al. 2004).  
Tomiya and colleagues showed that the exercise induced increase in plasma IL-6 was not directly 
correlated with myofibre expression of IL-6, which peaked much later.  For this reason, it 
remains possible that IL-6 levels in the muscular tissue, rather than plasma, are more closely 
related to extent of the antibody response to the vaccination.  It may be possible to examine this 
in a future study by conducting muscle biopsies on participants after a bout of eccentric exercise, 
and establish whether the subsequent vaccine response is associated with myofibre expression of 
IL-6, extracellular IL-6 levels in the muscle, or intracellular / homogenate expression of IL-6 in 
cellular infiltrate.    
 
A second difference between the two studies is the timing of IL-6 assessment.  In this study IL-6 
was measured 24 hr post-exercise, whereas in contrast, in the previous study, it was measured 6 
hr after exercise, immediately before vaccine administration (Edwards et al. 2007).  It is possible, 
therefore, that in Chapter Three the IL-6 response to exercise was confounded by an additional 
IL-6 response to vaccination (Tsai et al. 2005); the observed increase in IL-6 in the control group 
suggests that this is a plausible explanation.  In sum, the findings from this thesis do not support, 
but cannot exclude, the contention that IL-6 is a key mediator in the acute-stress enhancement of 
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vaccine responses.  Further research should establish whether intra-muscular levels of IL-6 are 
associated with improved vaccine responses. 
 
Enhancement of secondary responses to vaccination 
 
As discussed, Chapter Four found no effects of exercise on the antibody response to a single 
hepatitis B vaccine.  An alternative hypothesis for these null-findings relates to the choice of 
vaccine.  Other studies that have previously found adjuvant effects of acute concentric and 
eccentric exercise on vaccine responses have used either seasonal influenza (Edwards et al. 2006; 
Edwards et al. 2007) or meningococcal A+C vaccines (Edwards et al. 2008).  These vaccines 
differ from hepatitis B in terms of the probability of previous exposure to the antigen.  For 
example, influenza vaccine strains are specifically selected due to their high prevalence in the 
community in a particular season.  For this reason, naturalistic exposure, prior to vaccination, is 
relatively likely.  Further, seasonal influenza strains are fairly cross-reactive due to very limited 
mutations in the virus structure from season to season, a phenomenon known as antigenic drift 
(Nicholson et al. 2003).  It is likely, therefore, that many individuals will have been infected by, 
and have antibodies against, the same or similar viruses contained within the influenza vaccines.  
Similarly, individuals are likely to have some degree of immunity against both meningococcal 
A+C as a result of meningococcal C vaccine administered in childhood and the relatively high 
naturalistic exposure to these bacteria.  In contrast, hepatitis B is a blood-borne virus, usually 
transmitted via unsterile needles, unprotected sex, and direct blood-to-blood contact.  There is 
likely to be extremely low levels of exposure in the unvaccinated, young, healthy participants 
used in these studies; this was confirmed by the very low baseline antibody levels observed.  As 
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such, influenza and meningitis A+C are likely to induce secondary immune responses, whereas 
hepatitis B stimulates a primary immune response.  It is possible, therefore, that the effects of 
exercise are specific to secondary immune responses. 
 
This issue has been addressed directly in animals; Kapasi and colleagues compared the effects of 
acute exercise on both the primary and secondary immune responses to a novel antigen.  A single 
bout of intense exercise prior to HSA vaccination did not affect the primary antibody response, 
but did enhance the subsequent secondary response to a booster HSA vaccine in mice, compared 
with non-exercise controls (Kapasi et al. 2000).  These findings are in keeping with our 
hypothesis that secondary responses are more affected by acute behavioural intervention.  The 
mechanisms underpinning this effect are, as yet, undetermined, but Kapasi hypothesised that 
elevated noradrenaline during exercise may enhance specific antibody synthesis in response to an 
antigen.  Noradrenaline has been shown to promote antibody synthesis by increasing the number 
of antigen-specific B cells that differentiate into antibody-secreting plasma cells (Sanders and 
Powell-Oliver, 1992); such an effect may be particularly beneficial in a secondary immune 
response where this differentiation of existing antigen-specific B cells is a key process. 
 
Alternatively, it is possible to speculate that lymphocyte mobilization, observed with exercise 
(Bruunsgaard et al. 1997), might be particularly beneficial for secondary immune responses.  
Recent research has demonstrated that exercise causes a preferential mobilisation of effector 
lymphocytes into the bloodstream (Campbell et al. 2008; Campbell et al. 2009), and following 
eccentric exercise, are re-distributed to sites of muscle damage in the tissues (Miller, 2004).  
These effector lymphocytes exhibit pro-inflammatory capabilities, and upon antigen exposure can 
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release high levels of cytokines such as IFN-γ and TNF-α (Lanzavecchia and Sallusto, 2005).  
Crucially, using these cytokines, these cells are able to select the most suitable cells of the innate 
system, such as dendritic cells, and this priming leads to stronger adaptive immune responses that 
follow (Moretta, 2002; Moretta et al. 2005).  It is possible, therefore, that a mobilisation of 
effector lymphocytes during - and a subsequent re-distribution after exercise results in a more 
rapid, and more intensive, secondary response to antigenic challenge.   
 
FUTURE STUDIES 
 
It is clear from the issues raised in this thesis that further investigation into the exercise-induced 
augmentation of vaccine responses is warranted.  For example, it appears that exercise has an 
adjuvant effect on vaccines containing poorly immunogenic strains.  Given this, it would be 
interesting to test this hypothesis directly by measuring the efficacy of an exercise intervention on 
the antibody responses to different doses of a vaccine.  If the intervention could increase the 
response to a reduced dose vaccine to the levels observed with a standard dose, then this would 
be beneficial in circumstances where vaccine availability is reduced.  Alternatively, the adjuvant 
effect of exercise on poor immune response could be investigated by measuring the effects of 
exercise on the immune response to vaccination in immunologically compromised individuals.  
There are a host of different populations that may benefit from this approach.  For example, 
chronically stressed individuals have poorer responses to vaccination (Burns et al. 2003) and, as 
such, may benefit from immuno-enhancement at the time of vaccination.  Similarly, HIV patients 
are known to respond poorly to vaccination (Kroon et al. 1994).  Finally, there is now a wide 
body of research implicating immunological senescence (ageing) as an important factor in the 
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efficacy of vaccination (Effros, 2007).  Immunological senescence is characterised by an increase 
in cells with reduced telomere lengths that, upon antigen exposure, prevents the differentiation of 
antigen specific T and B cells, leading to a restriction of memory cells and an increased risk of 
infection (Effros, 2007).  An increase in senescent cells is thought to be responsible for the poor 
responses seen in the older adults to vaccination (Goodwin et al. 2006).  Indeed, the effectiveness 
of influenza vaccination in this population may be as low as 53 % (Villari et al. 2003).  For these 
reasons, it would be of pertinent interest to investigate whether these poorer responses can be 
enhanced by acute exercise, as has been shown in elderly mice (Kapasi et al. 2000).  It should be 
noted, however, that there is evidence that older adults also have reduced inflammatory responses 
to exercise (Przybyla et al. 2006), and this may impact upon the efficacy of this intervention.  It is 
conceivable that similar deficiencies may be observed in the responses of HIV patients, although 
to our knowledge this has never been directly tested.   
 
It would also be interesting to explore further the hypothesis that exercise has an adjuvant effect 
on the secondary, but not primary, immune responses to vaccination.  This has been investigated 
using an animal model (Kapasi et al. 2000), which found that exercise enhanced the secondary 
but not primary response to vaccination.  Clearly, it should be investigated more directly whether 
these findings are transferable to humans.  This study could be conducted by measuring the 
effects of exercise on the antibody response to a series of hepatitis B vaccinations.  The vaccine is 
poorly immunogenic and typically requires a series of booster vaccine shots.   The relative effects 
of exercise on primary and secondary immune responses could be investigated by measuring the 
antibody response to the first, and then subsequent, vaccinations.  Similarly, different groups 
could be exposed to exercise at each of the different vaccine administrations, to see if this 
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influenced the efficacy of the intervention.   Alternatively, a novel antigen known to induce a 
more robust primary antibody response, such as KLH, could be used, though the clinical 
relevance of this approach could be questioned due to the non-pathogenic nature of this protein.  
Finally, it would be desirable to measure both IgM and IgG responses, as this would enable a 
fuller investigation into primary responses than those measured in this thesis.   
 
Finally, future mechanistic studies should investigate whether the critical mediator of this 
response is a result of systemic changes in the inflammatory milieu, or instead, due to smaller 
changes within the damaged muscle tissue.  This issue has particular relevance given the recent 
findings of Prymula and colleagues.  This study investigated the effect of prophylactic 
paracetamol on fever and antibody responses to vaccination; they found that there was a 
substantial reduction in the primary antibody responses to each of ten pneumococcal conjugate 
vaccine serotypes and to Hib polysaccharide, diphtheria, tetanus, and pertactin antigens, in 
participants taking prophylactic paracetamol.  Importantly, this reduction was not associated with 
a reduction in systemic symptoms, such as fever.  They instead speculated  
prophylactic paracetamol interfered with the early interactions between APCs (e.g., dendritic 
cells and macrophages) and B cells and T cells, possibly through a reduction of inflammatory 
signals (e.g., prostaglandins) at the site of injection (Prymula et al. 2009).  It may be possible that 
acute exercise induces the opposite effect by upregulating the early interactions of between innate 
and adaptive immunity.  Future research could incorporate muscle biopsies to measure intra-
muscular levels of cytokines and cellular infiltrate.  This methodological strategy, although 
invasive, is likely to offer the best approach for identifying potential mechanisms underpinning 
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the adjuvant of exercise, as other indirect measures of muscle damage and inflammation may not 
provide a reliable indication of the actual intra-muscular environment.  
 
CONCLUSION 
 
The findings from this thesis support the acute-stress immuno-enhancement hypothesis, whereby 
acute eccentric exercise can, under certain circumstances, enhance the immune response to 
vaccination.  Results indicate that timing of vaccination after eccentric exercise does not affect 
the efficacy of the vaccine response.  In addition, it seems that altering the intensity of exercise 
does not affect the efficacy of the intervention, whereby exercise at 60 % IRM is just as 
efficacious as 110 % 1RM:  it is likely that a threshold effect of exercise exists.  In addition to 
previous exercise and vaccination studies in humans, my findings support the hypothesis that 
poorly immunogenic strains are enhanced by acute exercise, whereas robust responses are not.  
Finally, it is speculated from this thesis that exercise enhances the responses to secondary, as 
opposed to primary, immune responses to vaccination.  Taken together, these results support 
further investigation of this intervention in more clinical settings, in order to realise its potential 
benefits for immuno-compromised populations.   
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